September edition - American Academy of Neurology

Transcription

YOUR MONTHLY AAN MEMBERSHIP MAGAZINE
VOLUME 24
PRESIDENT’S COLUMN
AAN Advocacy Focuses on Patients
and the Profession, Not Ideologies
Advocacy is often the first topic of
conversation I have with almost every
neurologist I meet, whether it be at a
committee meeting, as a visiting professor,
or just in my personal interactions with
AAN members.
This focus on advocacy arises from
concerns about the potential and real
changes to the health care delivery
system being discussed in Washington.
Reimbursement for services has a
Bruce Sigsbee, MD, FAAN
substantial impact on both private and
academic practice as it becomes difficult
to make ends meet, especially for those who focus on and direct
patient evaluation and management, as opposed to procedures.
Today, the Academy is in a great position to advocate not only for
the profession of neurology but also for our patients. But it took a
while to get there.
ISSUE 9
SEPTEMBER 2011
Discover Your True Potential
Through the 2012 Palatucci
Advocacy Leadership Forum
AAN members have until
September 18 to complete their
applications to attend the 10th
Annual Donald M. Palatucci
Advocacy Leadership Forum.
The event will be held in Austin,
TX, January 12 to 15, 2012. This
award-winning training program is
open to international members as
well as those in the United States.
Participating in the Palatucci
Elaine C. Jones, MD, FAAN
Forum can be a life-changing
experience. Elaine C. Jones,
MD, FAAN, attended the first event in January 2003. She
recently discussed her reasons for applying and recalled
overcoming her initial trepidation as she embarked on a
fulfilling journey that helped her rise to the position of the
chair of the AAN’s Government Relations Committee:
Initially, there was concern that we would lose something as a
specialty if we became engaged in advocacy. But eventually, I
think we recognized that without a persistent and articulate voice,
the value of neurology would not be considered in the competing
demands for federal and state resources. To protect our specialty
and the access of patients to the expertise of neurologists, we had
to become effective advocates for what we do.
The Academy began a dramatic increase in the AAN’s advocacy
efforts in the early 2000s. For the first time, advocacy staff
was hired solely to represent the AAN and a concerted effort
was made to develop relationships with patient groups. A
Washington, DC, office opened in 2005 and a political action
committee, BrainPAC, was created in 2007. At the same time,
the AAN participation in committees dealing with coding and
reimbursement and quality measures was bolstered.
It is my own view that former US House Speaker Tip O’Neill’s
quote that “all politics are local” is not quite correct. I think that all
politics are personal. In the politics of neurology and health care it
is critical that we cultivate personal relationships with key figures
Teshamae Monteith, MD, (left) accepted the 2009 Palatucci Advocate
of the Year Award from Elaine C. Jones, MD, FAAN. “The Forum has given
me the training, skills and confidence to make the plight of headache sufferers
known, as well as the need for improved quality of care for headache
sufferers, especially veterans and active duty soldiers,” said Monteith.
Continued on page 3
p 15
Now Accepting Applications
for 2012 Scientific and
Non-scientific Awards
p 28
New ICD-9 Codes Affect
Neurologists Beginning
October 1
Continued on page 7
p 31
Neurology Career Week
Brings Job Opportunities,
Resources to Members
TABLE OF CONTENTS
OFFICIAL PUBLICATION OF THE
AMERICAN ACADEMY OF NEUROLOGY
COVER
AAN Advocacy Focuses on Patients and
the Profession, Not Ideologies
Discover Your True Potential Through
the 2012 Palatucci Advocacy
Leadership Forum
3 AAN Advocacy Focuses on Patients
and the Profession, Not Ideologies
ADVOCACY IN ACTION
4 Member Shares, Gains Insights as
Neurology Fellow on Congressional Staff
5 Apply for the Viste Patient Advocacy
Award by November 30
6 Independent Payment Advisory Board Has
Implications for AAN Members
7 Free Webinar to Discuss Viste
Neurology Public Policy Fellowship
13 Sports Concussion, Tort Reform
Make Headway in State Legislatures
ANNUAL MEETING
14 2012 Annual Meeting Set for Historic,
Vibrant New Orleans
15 Now Accepting Applications for 2012
Scientific and Non-scientific Awards
16 Abstracts Sought for Integrated
Neuroscience, Subspecialty in Focus
Programs
21 2012 Preliminary Education
Program Available
EDUCATION
24 Introducing Mobile Neurology CME
25 Fall Conference Programs Focus on
Improving Your Practice’s Bottom Line
26 The AAN Store Comes to Fall Conference
26 Two-day Evidence-based Medicine
Training Program Now Provides CME
27Continuum Call for Nominations:
Editor-in-Chief
OTHER
27 UCNS Practice Tracks in Headache
Medicine and Behavioral Neurology &
Neuropsychiatry Set to Expire in 2012
FOCUS ON PRACTICE
The Vision of the AAN is to be
indispensable to our members.
The Mission of the AAN is to promote
the highest quality patient-centered
neurologic care and enhance member
career satisfaction.
Contact Information
American Academy of Neurology
1080 Montreal Avenue
St. Paul, MN 55116 USA
Phone: (800)879-1960 or
(651) 695-2717 (International)
Fax:
(651)361-4800
Email: memberservices@aan.com
Website: www.aan.com
28 New ICD-9 Codes Affect Neurologists
Beginning October 1
29 Proposal 2012 Medicare Physician Fee
Schedule Includes AAN Quality Measures
29 Key Deadline Nears for EHR
Incentive Program
30 Registration Ends September 16 for
New Webinar on Negotiating with
Hospitals and Insurers
AAN Executive Director
Catherine M. Rydell, CAE
MEMBERSHIP
Managing Editor: Jason Kopinski
30 Olson to Be Honored by AMA
31 Neurology Career Week Brings Job
Opportunities, Resources to Members
31 Call for Volunteers for Neurology’s
Abstract Translation Project
32 New Recruitment Concierge Service
Assists in Finding Job Candidates
32 New AAN Headquarters Site Gets
Visit from Obama Administrator
Editor-in-Chief: John D. Hixson, MD
Editor: Tim Streeter
Writers: Ryan Knoke, Jay Mac Bride,
Sarah Parsons, and Lynn Ellen Smith
Designers: Siu Lee and Jim Hopwood
Email: aannews@aan.com
AANnews is published monthly by the
American Academy of Neurology.
Follow us and be a fan of the Academy:
FOUNDATION
33 Foundation Friends
34 | NEUROLOGY CAREER CENTER
37 | DATES AND DEADLINES
NEWS BRIEFS
• The AAN worked with four other specialties to submit proposed Current Procedural
Terminology ® (CPT) coding revisions to the EMG and nerve conduction codes following
a mandate to do so by CMS.
• In coordination with the American College of Sports Medicine, the AAN represented the
National Youth Sports Concussion Coalition at the National Conference of State Legislatures
Summit (NCSL) in San Antonio in August to promote the adoption of state legislation to reduce
youth sports concussion. State legislators from across the country attended the NCSL Summit.
• WriteClick, the rapid online correspondence section in Neurology ®, launched in August.
WriteClick, which will replace Neurology’s current correspondence section and will be edited by
Past President Robert C. Griggs, MD, FAAN, will appear on the home page of Neurology.
All members are invited to add to the online discussions regarding Neurology articles.
Learn from colleagues.
Share your insights.
Join AAN
Communities
today!
www.aan.com/communities
AAN Advocacy Focuses on Patients and the Profession, Not Ideologies
Continued from cover
in Washington and make our case personal. Our daily presence
in Washington and BrainPAC accomplish that for us.
Our successes since opening the DC office are measurable.
We have had legislation introduced and passed that specifically
benefits neurology and patients. Members of Congress routinely
contact our staff for help with crafting legislation and asking for
our support. Our views are considered like never before.
In my opinion, it is important that our advocacy efforts primarily
focus on issues that directly impact neurology. Our membership
has wide-ranging political views from ultraconservative to
ultraliberal and everything in between. Our Government
Relations Committee mirrors these widespread political views.
This can be a perilous situation when faced with issues that
go far beyond affecting just neurology. A perfect example is
the continuing consideration of the Affordable Care Act (ACA)
which began in 2009. The AAN has members disappointed, if
not angered, by our refusal to take a position on significant issues
such as the adoption of a single-payer system, at the same time
others demand support for a complete repeal of the ACA.
These issues transcend specialty care and neurology. There are
major systematic problems with our current health care delivery
system including lack of access for many and unsustainable
escalating cost.
But as a relatively small organization with limited resources,
the AAN’s position on a bill like the ACA is unlikely to change
the final outcome. On the other hand, there are components of
bills like the ACA where we can have a very real impact. That is
where we target our advocacy.
Regardless of our political views and passions, as neurologists
it is important that we all participate in the political process on
behalf of our profession and patients. Increasingly, decisions
in Washington and at all levels of government directly impact
day-to-day patient care. Our patients depend on us to effectively
advocate for their treatments. I encourage you to get to know
your elected officials and interact with them or their staff about
issues that are important to you on a regular basis. Work for and
contribute to candidates you believe in and cultivate long-term
relationships with policy makers. Consider running for office
yourself. The Academy can help in a number of ways including
Neurology on the Hill and the Palatucci Advocacy Leadership
Forum (see cover article). Both are extremely valuable
experiences. I hope you will join us in the political arena
on behalf of yourself, your profession, and your patients.
Bruce Sigsbee, MD, FAAN
President, AAN
ADVOCACY IN ACTION
ADVOCACY IN ACTION
Member Shares, Gains Insights as Neurology Fellow on Congressional Staff
As Larry Charleston, IV, MD, looked back on his experience
as the 2010-2011 Kenneth M. Viste, Jr., MD, Neurology Public
Policy Fellow (NPPF), one thing was abundantly clear to him:
“Politics play a major role in the administration and regulation
of health care services and delivery.”
Charleston worked for House Ways & Means Health Subcommittee
Chair Wally Herger (R-CA) during much of 2011. This was a
particularly revealing assignment as the House Ways & Means
Committee has dealt with taxes during the current tight fiscal
climate, and the Health Subcommittee was grappling with
numerous issues affecting health budgets.
Charleston said a key factor in his experience as a legislative
fellow was finding the “best fit” for his medical background and
personal philosophy. “My background and philosophy were
graciously and respectfully welcomed in Congressman Herger’s
office and I became a member of ‘Team Herger.’ The office
found it advantageous to utilize my hands-on medical expertise
including patient care, graduate medical education, and training
experiences and incorporate my experience in decisions for
‘real world’ applications of health care policy and legislation.
My portfolio included working on Medicare reform, physician
payment reform, helping to ensure appropriate congressional
awareness for the comprehensive diagnosis and treatment for
traumatic
brainKit
injury,
AEI: 11 veterans
AANStorewith
Residents
Survival
Ad and assisting Congressman
Usage: Herger
To be output
at High
Resolution
to be placed
in AANnews
on other
health
policyPDF
initiatives
within
his office and
Specs 8.125"x4.4375": Full bleed +0.125": 4C
the House Ways and Means Subcommittee on Health.”
Residents
and Fellows
Kit includes:
• QueenSquareHammer,Lanskaedition
• 2011 AAN Pocket Guidelines
• Ultimate Review for the
Neurology Boardsbook
Perfectforyourselforasagift
A particular anxiety of Herger’s is that
the scope of traumatic brain injury,
the signature wound of the Iraq and
Afghanistan wars, could overwhelm
the VA system. “He shared this concern
with me,” Charleston said, “and said that
we have to get ahead of the problem to
ensure that it is handled appropriately.
I worked hard to seize this opportunity
and to be very instrumental in assisting
him in addressing the problem. As a
result of Team Herger’s efforts, a Post
Larry Charleston, IV, MD
Traumatic Headache Consensus was
held in Washington, DC, led and
attended by members of the American Headache Society.”
Charleston’s activities also included speech writing, updating
Herger on current key health care policy issues, attending several
national health care policy forums and Alliance for Health
Care Reform discussions, and providing medical and training
insight to many health care issues brought by constituents and
organizations. He discussed issues with the Medicare Payment
Advisory Committee, helped to formulate questions for the
Ways & Means Health Subcommittee hearings, and assisted
in the drafts of legislation.
“During my tenure as a legislative fellow, I was able to
understand grassroots advocacy groups from a congressional
staff position. I staffed multiple meetings with constituents,
grassroots advocacy groups, organizations, and lobbyists.
“Overall, I learned a lot and gained some legislative insight in
a short time. Team Herger was awesome! They really helped
shape my experience and made a point to include me in
important health policy issues. Political decisions have a growing
impact on the practice and payment of medicine. I strongly
encourage physicians to find ways to actively participate in the
legislative process in addition to voting. Also, I encourage us all
to get more informed and examine health care policy related
legislation (actual and proposed) as well as proposed rules
through direct, unfiltered sources.”
Charleston’s months in Washington strengthened his belief in the
necessity of physician activism. “As neurologists, we can bring
the voice of our patients to the legislators revamping our nation’s
health care system and foster remarkable changes. Patients
Academy Seeks Applicants for
Unique Washington, DC, Fellowship
Academy members in the US are urged to apply for the
2012–2013 Kenneth M. Viste, Jr., MD, Neurology Public Policy
Fellowship by October 15. The fellowship enables AAN members
to get firsthand experience in the halls of Congress, including:
•Helping draft legislation and taking active part in the
policy process
•Working with constituents, lobbyists, and congressional
committee and office staff
•Participating in hearings and special sessions related to policy
The fellowship carries an annual stipend of $90,000, which may
be supplemented by the fellow’s sponsoring institution or other
extramural support. Up to $6,000 is available for relocation.
Continued on page 5
Career Kit
need competent neurologists who, in addition to providing
high-quality neurological care, will advocate for change when
they see injustice in clinical practice. The AAN provides multiple
advocacy resources and activities where neurologists can make
significant differences within the practice of neurology. As the sixth
president of the United States, John Quincy Adams, once said,
‘Duty is ours, results are God’s.’ I believe it is our responsibility to
exercise our freedom to be a conduit for the voice of our patients,
profession, and medical colleagues. This great voice should help
mold the reshaping of our health care system.”
Larry Charleston, IV, MD, worked on neurology and medical issues with
Congressman Wally Herger during his Viste Neurology Public Policy Fellowship.
More details on the award, which is sponsored by the
AAN, the American Neurological Association, and the
Child Neurology Society, can be found at www.aan.com/viste,
or by contacting Mike Amery at mamery@aan.com. Register
for a free informational webinar held on September 19 at
12:00 p.m. ET at readytalk.com/r/tlh6cojxrc43.
Apply for the Viste Patient Advocacy Award by November 30
Each year, the AAN presents the Kenneth M. Viste, Jr., MD, Patient Advocacy Award to a neurologist who
exemplifies the kind of leadership and commitment to advocating for the patient community as shown by the
award’s namesake. The recipient of this award will have demonstrated a sincere interest and investment in
working on behalf of patients with neurologic conditions.
In addition to being a former president of the AAN and chair of the AAN Foundation at the time of his death
in 2004, Kenneth M. Viste, Jr., MD, was a distinguished neurologist and tireless advocate for his patients.
His dedication to improving the lives of others was lauded by his peers and inspired his community.
To nominate a colleague or to apply, submit the following:
Great value: $89.00
Morethan20%savingsthanif
purchasedseparately
•A written description of the candidate’s success relating to patient advocacy
• If applying, a letter of endorsement from a current AAN member
•A list of additional supporters (if any)
•A current copy of the candidate’s curriculum vitae
www.aan.com/store
Applications must be received by November 30, 2011. The recipient will receive a $1,000 honoraria and recognition during the
2012 AAN Annual Meeting in New Orleans. The award is sponsored by the AAN and its Foundation and endowed by gifts from
Viste’s friends and colleagues to the Kenneth M. Viste, Jr., MD, Leadership Fund.
Kenneth M. Viste, Jr., MD, FAAN
For more information, visit www.aan.com/visteaward or contact Julie Grengs at jgrengs@aan.com or (651) 695-2755.
Save Time · Save Money · Shop The AAN Store
AANnews • September 2011
5
ADVOCACY IN ACTION
ADVOCACY IN ACTION
Independent Payment Advisory Board
Has Implications for AAN Members
In an effort to reduce the growth of Medicare spending, the
Patient Protection and Affordable Care Act mandated creating the
Independent Payment Advisory Board (IPAB), an outside entity
charged with developing cost-saving proposals that would also
preserve the quality and access to care for Medicare beneficiaries.
Starting in 2013, the Centers for Medicare & Medicaid Services
(CMS) will project whether or not Medicare’s per-capita
spending growth rate in the following two years will exceed
a targeted rate. If projected Medicare spending exceeds the
targets, IPAB will propose recommendations to Congress and
the president by January 15 the following year on how to reduce
the rate. Should Congress take no action by August 15 of that
year, IPAB’s proposals will become law and will be automatically
implemented by the Department of Health and Human Services
(HSS). IPAB’s first proposal with the board’s recommendations
would be submitted on January 15, 2014.
Here is a brief summary of what neurologists need to know
about IPAB and its charter.
Discover Your True Potential Through the 2012 Palatucci Advocacy
Leadership Forum
Continued from cover
Implications for Neurology
While the goal of the IPAB is to reduce Medicare spending and
maintain quality of care and access for Medicare beneficiaries,
its cost-saving recommendations are limited. Essentially, the
Board is prohibited from raising beneficiary premiums or
restricting benefits. It is not prohibited, however, from cutting
payments to health care providers and suppliers, which will most
likely translate into reducing payments to physicians. Hospitals
and hospice are exempted from IPAB’s recommendations for the
first four years and clinical labs are exempt for one year. In this
respect, neurologists and other physicians providing services to
Medicare patients might be subject to the first payment cuts.
Currently, physicians would already face payment cuts if the
Sustainable Growth Rate formula (SGR), otherwise known as
the Medicare reimbursement rate, were to be implemented. The
nearly 30-percent SGR cut has been delayed until January 1, 2012,
to a large extent, thanks to advocating efforts of the physician and
patients’ community. Under IPAB such efforts will be limited.
“I wasn’t really sure exactly what it was but I was intrigued
by the word ‘advocate’ and wanted to take a larger role in my
profession. There are tons of reasons to get involved in the PALF
program and for me it was about professional development.
I truly had no idea what I was getting into or where it would
lead. Prior to this program I hadn’t been involved in the
Academy other than attending some Annual Meetings. When
I was accepted I was excited but a bit nervous because I didn’t
know what would be expected of me. When I went to the first
reception it was a little scary because I didn’t know anyone!
It took about five minutes for the butterflies to go away. Few
people knew each other. Everyone was excited and interested
in learning about each other. The AAN staff leading the program
was friendly, excited, and reassuring. They made a point to
engage people, explain what was expected of us, and emphasize
that this was going to be a FUN weekend.
“It was one of the most rewarding and exciting experiences of
my professional life. I came away energized and with a whole
new set of skills. I had also made some friends who, to this day
remain close, both personally and professionally.
IPAB’s Board Members
The board will be comprised of 15 experts, each nominated
for six-year terms by the president and confirmed by the
Senate; and three nonvoting members: the secretary of HHS,
the administrator of the Center for Medicare & Medicaid
Services, and the administrator of the Health Resources
and Services Administration. Board members should
be nationally recognized for their expertise in actuarial
science, health finance, health facility management, health
plans and delivery systems, and provide broad geographic
representation.
Inevitably, Medicare patients’ quality of service and access
to care will suffer if a large number of neurologists leave the
Medicare program due to difficulties remaining profitable.
Neurology already is facing difficulties as a cognitive specialty
left out of the ‘evaluation and management’ incentive offered to
primary care providers. Lower reimbursement rates under this
plan most likely would exacerbate these problems.
IPAB’s Proposals
The IPAB’s proposals cannot recommend rationing health
care, raising cost-sharing (including Part A and B premiums)
or restricting benefits or eligibility criteria for program’s
beneficiaries in any other way. It should limit Medicare
spending by identifying sources of excess cost growth while
protecting and improving Medicare beneficiaries’ access to
services.
Most importantly, as an independent entity, the IPAB was
granted the authority to create proposals that become laws
without congressional action. The board would be only
accountable to the president, who appoints its members, so
oversight of its work will be highly limited.
“The skills I learned that year and in subsequent years have helped
me develop in a professional direction that I never imagined.
So many doctors complain about the way our profession is
heading. We have less time with patients, less autonomy,
less satisfaction, and yes, less income. I am trying to be part
of the solution rather than continuing to let others take more
control. Whether someone wants to improve access to care for a
certain patient group, develop support for patients and families,
or change regulations that affect our field and our patients, the
training at the Palatucci Forum will give them skills and resources
to do this. The AAN leaders and staff, the training at the Palatucci
Forum, and the connections/friends made during the weekend
will aid any neurologist in pursuing these improvements.
Academy Support for Repealing IPAB
”Finally, I like to point out that no one should be afraid of failure.
In addition, hospitals and hospice will not be subject to cost
reductions proposed by the board from 2015 through 2019.
Clinical labs also would be exempt for one year.
IPAB’s Advisory Reports
Besides submitting cost-saving proposals, IPAB also may
develop and submit to Congress advisory reports related to
Medicare spending. These reports can be submitted each
year, beginning January 15, 2014, but they are not to be
automatically implemented. For years prior to 2020, advisory
reports may include recommendations on how to change
payment systems for providers and suppliers in the private
sector who are not subject to the board’s proposals.
If the board establishes a successful method to control spending
for health care providers and suppliers, the private sector may
adopt some of the same methods or pressure physicians to offer
them similar conditions.
The AAN supports the bipartisan efforts in Congress to eliminate
the IPAB and has signed on to a letter with hundreds of other
physician organizations asking for its repeal. The IPAB effectively
removes Medicare spending decisions from Congress and leaves
them up to an unelected, unaccountable board. Decisions made
by the board likely will have a negative impact on patient access
to care by adding to the number of physicians who have already
stopped accepting new Medicare patients.
Members are encouraged to contact their elected officials in
Washington asking them to support the IPAB’s repeal.
To review tables that outline how Medicare projected and
targeted growth rates and saving targets are to be determined,
visit www.aan.com/view/ipabchart. For more information,
contact Mike Amery at mamery@aan.com.
AANnews • September 2011 6
I still have not been fully successful
in my initial Forum project. My
project was to reconcile two
neurology professional societies
in Rhode Island back into one.
I wanted to re-energize and
strengthen our professional group
by getting rid of a ‘town-gown’
split that had occurred many years
ago. While this hasn’t completely
happened yet, we collaborate more, meet
jointly more, and continue to work towards a single stronger
voice for neurology in our state. I have learned that success may
come in other forms than you first expected. From starting down
this road, many other opportunities and projects have come
up in which I have been successful. Thanks to the Palatucci
Forum, I realize that trying and failing is better than never trying
at all. Who knows where it may lead? I am now the chair of the
Government Relations Committee for the AAN. I certainly didn’t
foresee that when I showed up at that first evening reception.
Sometimes all you have to do is take the first step.”
Across the world, 270 AAN-trained advocates have been
changing lives and improving their profession in significant
and lasting ways. Palatucci Forum graduates have successfully
advocated for new stroke care centers and time-saving
telemedicine initiatives. They have fought for patients to have
access to a wider range of antiepileptic drugs, against scope
of practice intrusions, and for medical liability reform. Many
of these neurologists had no prior advocacy or leadership
experience, but they quickly gained confidence and skills
through this comprehensive award-winning program. And many,
like Jones, have gone on to be leaders in Academy activities.
For more information or to apply before the September 18
deadline, visit www.aan.com/view/2012PALF or contact
Melissa Larson at mlarson@aan.com or (651) 695-2748.
Free Webinar to Discuss Viste Neurology
Public Policy Fellowship
Monday, September 19, 2011, at 12:00 p.m. ET
AAN Legislative Counsel Mike Amery hosts a live webinar from Washington, DC, for Academy
members interested in learning more about working on Capitol Hill for up to a year as a Kenneth M.
Viste, Jr., MD, Neurology Public Policy Fellow. Find out how you can play a role in representing the
interests of neurology during this crucial time for your profession.
Register by September 15 at readytalk.com/r/tlh6cojxrc43.
moderAte-to-severe primAry
restless legs syndrome (rls)
INTROducINg A first-in-clAss non-dopAminergic treAtment for
moderAte-to-severe primAry restless legs syndrome in Adults
INdIcATION
HORIZANT (gabapentin enacarbil) is indicated for the treatment of moderate-to-severe
primary Restless Legs Syndrome (RLS) in adults. HORIZANT is not recommended for
patients who are required to sleep during the daytime and remain awake at night.
four essential diagnostic criteria for RLS2:
• Urge to move the legs—usually accompanied or caused
by uncomfortable and unpleasant leg sensations
• Symptoms begin or worsen during periods of rest or
inactivity such as lying or sitting
• Symptoms are partially or totally relieved by movement
(walking or stretching) at least as long as the activity continues
• Symptoms are worse in the evening or night than during the day
or only occur in the evening or night
ImPORTANT SAfeTy INfORmATION
• HORIZANT 600 mg once daily is the only approved dose.
A daily dose of 1,200 mg provided no additional benefit
compared with the 600-mg dose, but caused an increase
in adverse reactions
Effects on Driving
• HORIZANT causes significant driving impairment.
Patients on HORIZANT should not drive until they have
sufficient experience to know whether their ability to
drive is impaired. The patients’ ability to assess their
driving competence and their ability to assess the
degree of somnolence caused by HORIZANT can be
imperfect
Somnolence/Sedation and Dizziness
• HORIZANT causes somnolence/sedation and dizziness.
Patients should not drive or operate other complex
machinery until they have sufficient experience on
HORIZANT to know whether their ability to perform
these tasks is impaired
Lack of Interchangeability With Gabapentin
• HORIZANT is not interchangeable with other gabapentin
products due to differing pharmacokinetic profiles. The
same dose of HORIZANT results in different plasma
concentrations of gabapentin relative to other gabapentin
products. Safety and effectiveness of HORIZANT to treat
epilepsy is unknown
ImPORTANT SAfeTy INfORmATION (cONTINued)
Suicidal Behavior and Ideation
• HORIZANT (gabapentin enacarbil) is a prodrug of
gabapentin, an antiepileptic drug (AED). AEDs increase
the risk of suicidal thoughts or behavior in patients
taking these drugs for any indication. As a prodrug of
gabapentin, HORIZANT also increases this risk. Patients
treated with any AED for any indication should be
monitored for new or worsening depression, suicidal
thoughts or behavior, and/or any unusual changes in
mood or behavior. Anyone considering prescribing
HORIZANT must balance the risk of suicidal thoughts or
behavior with the risk of untreated illness.
Patients, caregivers, and families should be informed
that HORIZANT increases the risk of suicidal thoughts
and behavior and should be advised of the need to
be alert for new or worsening signs and symptoms of
depression, any unusual changes in mood or behavior,
or the emergence of suicidal thoughts, behavior, or
thoughts of self-harm. Behaviors of concern should be
reported immediately to healthcare providers
Adverse Reactions
• The most common adverse reactions for HORIZANT 600 mg,
1,200 mg, and placebo, respectively, were somnolence/
sedation (20%, 27%, and 6%), dizziness (13%, 22%, and 4%),
headache (12%, 15%, and 11%), nausea (6%, 7%, and 5%),
and fatigue (6%, 7%, and 4%)
Discontinuation of HORIZANT
• Patients receiving the recommended 600-mg/day
dose can discontinue the drug without tapering. If this
dose is exceeded, reduce the dose to 600 mg/day for
1 week prior to discontinuation to minimize potential
for withdrawal seizure
Tumorigenic Potential
• In an oral carcinogenicity study, gabapentin enacarbil
increased the incidence of pancreatic acinar cell
adenoma and carcinoma in male and female rats.
The clinical significance of this finding is unknown
Please see brief summary of Prescribing Information for HORIZANT
on following pages.
Visit gsksource.com for more information about HORIZANT.
References: 1. Garcia-Borreguero D, Egatz R, Winkelmann J, Berger K.
Epidemiology of restless legs syndrome: the current status. Sleep Med Rev.
2006;10:153-167. 2. Allen RP, Picchietti D, Hening WA, et al. Restless legs
syndrome: diagnostic criteria, special considerations, and epidemiology:
a report from the restless legs syndrome diagnosis and epidemiology
workshop at the National Institutes of Health. Sleep Med. 2003;4:101-119.
For:
Licensed from:
©2011 The GlaxoSmithKline Group of Companies and XenoPort, Inc.
All rights reserved. Printed in USA. GEN056R0 September 2011
BRIEF SUMMARY
HORIZANT
™
(gabapentin enacarbil)
Extended-Release Tablets
The following is a brief summary only; see full Prescribing Information for complete
product information.
INDICATIONS AND USAGE
HORIZANT™ (gabapentin enacarbil) Extended-Release Tablets are indicated for the
treatment of moderate-to-severe primary Restless Legs Syndrome (RLS) in adults.
HORIZANT is not recommended for patients who are required to sleep during the daytime
and remain awake at night.
CONTRAINDICATIONS
None.
WARNINGS AND PRECAUTIONS
Effects on Driving
HORIZANT causes significant driving impairment. Patients being treated with HORIZANT
should not drive until they have gained sufficient experience to assess whether HORIZANT
impairs their ability to drive. However, prescribers and patients should be aware that
patients’ ability to assess their own driving competence, as well as their ability to assess the
degree of somnolence caused by HORIZANT, can be imperfect.
In a 2-week simulated driving study in patients with RLS, a daily 1,200-mg dose of
HORIZANT caused significant impairment within 2 hours and for up to 14 hours after
dosing. The impairment was similar to that caused by the active control, a single oral dose
of diphenhydramine 50 mg. The effect on driving at times other than 2 weeks is unknown.
Whether the impairment is related to somnolence [see Somnolence/Sedation and Dizziness]
or other effects of HORIZANT is unknown. The 600-mg dose was not studied. Because a
600-mg/day dose of HORIZANT can cause significant somnolence, similar to that of the
1,200-mg/day dose [see Somnolence/Sedation and Dizziness], the 600- and 1,200-mg/day
doses may have similar effects on driving behavior.
HORIZANT causes somnolence/sedation and dizziness (see Table 2). Patients should
be advised not to drive a car or operate other complex machinery until they have gained
sufficient experience on HORIZANT to assess whether HORIZANT impairs their ability to
perform these tasks.
During the controlled trials in patients with RLS, somnolence/sedation was reported in 20%
of patients treated with 600 mg of HORIZANT per day compared with 6% of patients receiving
placebo. In those patients treated with HORIZANT who reported somnolence, the somnolence
persisted during treatment in about 30%. In the remaining patients, symptoms resolved within
3 to 4 weeks. Dizziness was reported in 13% of patients receiving 600 mg of HORIZANT per
day compared with 4% of patients receiving placebo. In those patients treated with HORIZANT
who reported dizziness, symptoms persisted during treatment in about 20%.
Somnolence/sedation led to withdrawal in 2% of patients receiving 600 mg of HORIZANT
per day. Dizziness led to withdrawal in 1% of patients receiving 600 mg of HORIZANT per day.
The incidence of these adverse reactions was greater in the patients receiving 1,200 mg per day.
HORIZANT is not interchangeable with other gabapentin products because of differing
pharmacokinetic profiles. The same dose of HORIZANT results in different plasma
concentrations of gabapentin relative to other gabapentin products. [See Clinical Pharmacology (12.3) of full prescribing information.]
The safety and effectiveness of HORIZANT in patients with epilepsy have not been studied.
HORIZANT (gabapentin enacarbil) is a prodrug of gabapentin, an antiepileptic drug (AED).
AEDs increase the risk of suicidal thoughts or behavior in patients taking these drugs for any
indication. Because HORIZANT is a prodrug of gabapentin, HORIZANT also increases this
risk. Patients treated with any AED for any indication should be monitored for the emergence
or worsening of depression, suicidal thoughts or behavior, and/or any unusual changes in
mood or behavior.
Pooled analyses of 199 placebo-controlled clinical trials (monotherapy and adjunctive
therapy) of 11 different AEDs showed that patients randomized to 1 of the AEDs had
approximately twice the risk [adjusted relative risk 1.8, 95% confidence interval (CI): 1.2,
2.7] of suicidal thinking or behavior compared with patients randomized to placebo. In these
trials, which had a median treatment duration of 12 weeks, the estimated incidence rate of
suicidal behavior or ideation among 27,863 AED-treated patients was 0.43%, compared with
0.24% among 16,029 placebo-treated patients, representing an increase of approximately 1
case of suicidal thinking or behavior for every 530 patients treated. There were 4 suicides in
drug-treated patients in the trials and none in placebo-treated patients, but the number is too
small to allow any conclusion about drug effect on suicide.
The increased risk of suicidal thoughts or behavior with AEDs was observed as early as
1 week after starting drug treatment with AEDs and persisted for the duration of treatment
assessed. Because most trials included in the analysis did not extend beyond 24 weeks, the
risk of suicidal thoughts or behavior beyond 24 weeks could not be assessed.
The risk of suicidal thoughts or behavior was generally consistent among drugs in the data
analyzed. The finding of increased risk with AEDs of varying mechanisms of action and across
a range of indications suggests that the risk applies to all AEDs used for any indication. The
risk did not vary substantially by age (5 to 100 years) in the clinical trials analyzed. Table 1
shows absolute and relative risk by indication for all evaluated AEDs.
Table 1. Risk by Indication for Antiepileptic Drugs in the Pooled Analysis
Relative Risk:
Placebo
Drug
Incidence
Risk Difference:
Patients
Patients
of Events in
Additional
With Events With Events
Drug Patients/
Drug Patients
Per 1,000
Per 1,000
Incidence in
With Events Per
Indication
Patients
Patients
Placebo Patients
1,000 Patients
Epilepsy
1.0
3.4
3.5
2.4
Psychiatric
5.7
8.5
1.5
2.9
Other
1.0
1.8
1.9
0.9
Total
2.4
4.3
1.8
1.9
The relative risk for suicidal thoughts or behavior was higher in clinical trials for epilepsy
than in clinical trials for psychiatric or other conditions, but the absolute risk differences were
similar for the epilepsy and psychiatric indications.
Anyone considering prescribing HORIZANT must balance the risk of suicidal thoughts or
behavior with the risk of untreated illness. Epilepsy and many other illnesses for which AEDs
are prescribed are themselves associated with morbidity and mortality and an increased risk
of suicidal thoughts and behavior. Should suicidal thoughts and behavior emerge during
treatment, the prescriber needs to consider whether the emergence of these symptoms in
any given patient may be related to the illness being treated.
Patients, their caregivers, and families should be informed that HORIZANT increases the
risk of suicidal thoughts and behavior and should be advised of the need to be alert for the
emergence or worsening of the signs and symptoms of depression, any unusual changes in
mood or behavior, or the emergence of suicidal thoughts, behavior, or thoughts about
self-harm. Behaviors of concern should be reported immediately to healthcare providers.
Discontinuation of HORIZANT
When discontinuing HORIZANT, patients receiving the recommended dose of 600 mg
daily can discontinue the drug without tapering. If the recommended dose is exceeded, the
dose should be reduced to 600 mg daily for 1 week prior to discontinuation to minimize the
potential of withdrawal seizure.
Tumorigenic Potential
In an oral carcinogenicity study, gabapentin enacarbil increased the incidence of
pancreatic acinar cell adenoma and carcinoma in male and female rats [see Nonclinical
Toxicology]. The clinical significance of this finding is unknown.
In clinical studies of gabapentin as adjunctive therapy in epilepsy comprising 2,085
patient-years of exposure in patients >12 years of age, new tumors were reported in 10
patients (2 breast, 3 brain, 2 lung, 1 adrenal, 1 non-Hodgkin’s lymphoma, 1 endometrial
carcinoma in situ), and preexisting tumors worsened in 11 patients (9 brain, 1 breast, 1
prostate) during or up to 2 years following discontinuation of gabapentin. Without knowledge
of the background incidence and recurrence in a similar population not treated with
gabapentin, it is impossible to know whether the incidence reported in this cohort is or is not
affected by treatment.
ADVERSE REACTIONS
Because clinical trials are conducted under widely varying conditions, adverse reaction
rates observed in the clinical trials of a drug cannot be directly compared with rates in the
clinical trials of another drug and may not reflect the rates observed in practice.
Clinical Trials Experience
In all controlled and uncontrolled trials across various patient populations prior to
approval of HORIZANT, more than 2,300 patients have received HORIZANT orally in daily
doses ranging from 600 to 3,600 mg.
The exposure to HORIZANT in 1,201 patients with RLS included 613 exposed for at
least 6 months and 371 exposed for at least 1 year. HORIZANT in the treatment of RLS was
studied primarily in placebo-controlled trials (n = 642), and in long-term follow-up studies.
The population with RLS ranged from 18 to 82 years of age, with 60% being female and
95% being Caucasian.
The safety of HORIZANT in doses ranging from 600 to 2,400 mg has been evaluated
in 515 patients with RLS in 3 double-blind, placebo-controlled, 12-week clinical trials. The
600-mg dose was studied in 2 of the 3 studies. Eleven out of 163 (7%) patients treated with
600 mg of HORIZANT discontinued treatment due to adverse reactions compared with 10 of
the 245 (4%) patients who received placebo.
The most commonly observed adverse reactions (≥5% and at least 2 times the rate of
placebo) in these trials for the 600-mg dose of HORIZANT were somnolence/sedation and
dizziness (see Table 2). Table 2 lists treatment-emergent adverse reactions that occurred in
≥2% of patients with RLS treated with HORIZANT and numerically greater than placebo.
Table 2. Incidence of Adverse Reactions in 12-Week RLS Studies Reported in
≥2% of Patients Treated With 600 or 1,200 mg of HORIZANT and Numerically
Greater Than Placebo
Body System/
Adverse Reaction
Nervous system disorders
Somnolence/sedation
Dizziness
Headache
Gastrointestinal disorders
Nausea
Dry mouth
Flatulence
Placeboa
(N = 245)
%
HORIZANT
600 mg/dayb
(N = 163)
%
HORIZANT
1,200 mg/dayc
(N = 269)
%
6
4
11
20
13
12
27
22
15
5
2
<1
6
3
3
7
4
2
Table 2 (continued). Incidence of Adverse Reactions in 12-Week RLS Studies Nursing Mothers
It is not known whether gabapentin derived from HORIZANT is secreted in human milk;
Reported in ≥2% of Patients Treated With 600 or 1,200 mg of HORIZANT and
however, gabapentin is secreted into human milk following oral administration of gabapentin
Numerically Greater Than Placebo
Placeboa
(N = 245)
%
HORIZANT
600 mg/dayb
(N = 163)
%
HORIZANT
1,200 mg/dayc
(N = 269)
%
Body System/
Adverse Reaction
General disorders and
administration site conditions
Fatigue
4
6
7
Irritability
1
4
4
Feeling drunk
0
1
3
Feeling abnormal
<1
<1
3
Peripheral edema
1
<1
3
Metabolism and
nutritional disorders
Weight increased
2
2
3
Increased appetite
<1
2
2
Ear and labyrinth disorders
Vertigo
0
1
3
Psychiatric disorders
Depression
<1
<1
3
Libido decreased
<1
<1
2
a
Placebo was a treatment arm in each of the 3 double-blind, placebo-controlled,
12-week clinical trials.
b
The 600-mg dose of HORIZANT was a treatment arm in 2 of the 3 double-blind, placebocontrolled, 12-week clinical trials.
c
The 1,200-mg dose of HORIZANT was a treatment arm in each of the 3 double-blind,
placebo-controlled, 12-week clinical trials.
Adverse reactions reported in these three 12-week studies in <2% of patients treated with
600 mg of HORIZANT and numerically greater than placebo were balance disorder, blurred
vision, disorientation, feeling drunk, lethargy, and vertigo.
The following adverse reactions were dose-related: somnolence/sedation, dizziness,
feeling drunk, libido decreased, depression, headache, peripheral edema, and vertigo.
DRUG INTERACTIONS
Neither gabapentin enacarbil nor gabapentin are substrates, inhibitors, or inducers of the
major cytochrome P450 enzymes. Gabapentin enacarbil is neither a substrate nor an
inhibitor of P-glycoprotein in vitro.
Pharmacokinetic drug-drug interaction studies were conducted to examine the potential
for an interaction of gabapentin enacarbil with cimetidine and naproxen. No significant
pharmacokinetic interactions were observed. No clinically relevant pharmacokinetic
interactions are expected between HORIZANT and other substrates of organic cation
transporter type 2 (OCT2) and monocarboxylate transporter type 1 (MCT-1) [see Clinical
Pharmacology (12.3) of full prescribing information].
USE IN SPECIFIC POPULATIONS
Pregnancy
Pregnancy Category C. There are no adequate and well-controlled studies with HORIZANT
in pregnant women. In nonclinical studies in rat and rabbits, administration of gabapentin
enacarbil was developmentally toxic when administered to pregnant animals at doses and
gabapentin exposures greater than those used clinically. HORIZANT should be used during
pregnancy only if the potential benefit justifies the potential risk to the fetus.
When pregnant rats were administered gabapentin enacarbil (oral doses of 200, 1,000,
or 5,000 mg/kg/day) throughout the period of organogenesis, embryo-fetal mortality was
increased at the 2 highest doses and fetal body weights were decreased at the high dose. The
no-effect dose for embryo-fetal developmental toxicity in rats is approximately 3 times the
recommended human dose (RHD) of 600 mg/day on a body surface area (mg/m2) basis.
When pregnant rabbits were administered gabapentin enacarbil (oral doses of 200, 500,
or 2,500 mg/kg/day) throughout the period of organogenesis, embryo-fetal mortality was
increased and fetal body weights were decreased at the high dose. The no-effect dose for
embryo-fetal developmental toxicity in rabbits (500 mg/kg/day) is approximately 16 times the
RHD on a mg/m2 basis.
When female rats were administered gabapentin enacarbil (oral doses of 200, 1,000,
or 5,000 mg/kg/day throughout the pregnancy and lactation periods, offspring growth and
survival were decreased at the two highest doses. The no-effect dose for pre- and post-natal
developmental toxicity in rats is approximately 3 times the RHD on a mg/m2 basis.
In reproductive and developmental studies of gabapentin, developmental toxicity was
observed at all doses tested. Increased incidences of hydroureter and/or hydronephrosis
were observed in rat offspring following treatment of pregnant animals in studies of fertility
and general reproductive performance, embryo-fetal development, and peri- and post-natal
development. Overall, a no-effect dose was not established. In mice, treatment of pregnant
animals with gabapentin during the period of organogenesis resulted in delayed fetal
skeletal ossification at all but the lowest dose tested. When pregnant rabbits were treated
with gabapentin during the period of organogenesis, an increase in embryo-fetal mortality
was observed at all doses of gabapentin tested.
In a published study, gabapentin (400 mg/kg/day) was administered by intraperitoneal
injection to neonatal mice during the first postnatal week, a period of synaptogenesis in rodents
(corresponding to the last trimester of pregnancy in humans). Gabapentin caused a marked
decrease in neuronal synapse formation in brains of intact mice and abnormal neuronal synapse
formation in a mouse model of synaptic repair. Gabapentin has been shown in vitro to
interfere with activity of the α2δ subunit of voltage-activated calcium channels, a receptor
involved in neuronal synaptogenesis. The clinical significance of these findings is unknown.
Labor and Delivery
The effect of HORIZANT on labor and delivery is unknown.
products. Because of the potential for adverse reactions in nursing infants from HORIZANT,
a decision should be made whether to discontinue nursing or to discontinue the drug,
taking into account the importance of the drug to the mother.
Pediatric Use
Safety and effectiveness of HORIZANT in pediatric patients have not been studied.
Geriatric Use
Of the 515 patients treated with HORIZANT in the 3 double-blind, placebo-controlled,
12-week clinical trials for RLS, 11% were 65 to 74 years of age and 1% were 75 years of age
and older. Clinical trials of HORIZANT did not include a sufficient number of patients 65 years
and older to determine whether they respond differently from younger individuals.
Gabapentin is known to be almost exclusively excreted by the kidney, and the risk of
adverse reactions to this drug may be greater in patients with impaired renal function.
Because elderly patients are more likely to have decreased renal function, the frequency of
dosing may need to be adjusted based on calculated creatinine clearance in these patients
[see Dosage and Administration (2.2) of full prescribing information].
Renal Impairment
The dose of HORIZANT should be adjusted in patients with renal impairment [see Dosage
and Administration (2.2), Clinical Pharmacology (12.3) of full prescribing information].
OVERDOSAGE
Human Overdose Experience
There have been no reports describing individuals who have taken an overdose of
HORIZANT. The highest single dose of gabapentin enacarbil administered to date is 6,000 mg
in healthy subjects. At this supratherapeutic dose there were no serious adverse events.
The incidence of central nervous system adverse reactions, particularly dizziness and
somnolence/sedation, is increased with doses greater than 600 mg daily.
Overdosage Management
In the event of an overdose, the patient should be treated supportively with appropriate
monitoring as necessary. Gabapentin derived from gabapentin enacarbil can be removed by
hemodialysis. Standard hemodialysis procedures result in significant clearance of gabapentin.
Further management should be as clinically indicated or as recommended by a poison
control center.
PATIENT COUNSELING INFORMATION
See Medication Guide.
Physicians should instruct their patients to read the Medication Guide before starting
therapy with HORIZANT and to reread it upon prescription renewal for new information
regarding the use of HORIZANT.
Effects on Driving
Patients should be told that HORIZANT can cause significant driving impairment.
Accordingly, they should be advised not to drive a car or until they have gained sufficient
experience on HORIZANT to assess whether HORIZANT impairs their ability to drive.
Patients should be told that it is not known how long this effect lasts.
Patients should be told that HORIZANT can cause significant somnolence and dizziness.
This typically resolves within several weeks of initiating treatment. Accordingly, they should
be told not to operate dangerous machinery until they have gained sufficient experience on
HORIZANT to assess whether HORIZANT impairs their ability to operate dangerous
machinery safely.
Patients, their caregivers, and families should be counseled that HORIZANT may increase
the risk of suicidal thoughts and behavior, and should be advised of the need to be alert for
the emergence or worsening of symptoms of depression, any unusual changes in mood
or behavior, or the emergence of suicidal thoughts, behavior, or thoughts about self-harm.
Behaviors of concern should be reported immediately to healthcare providers.
Patients should be advised that doses of HORIZANT and other gabapentin products are
not interchangeable.
Dosing Instructions
• Patients should be instructed to take HORIZANT only as prescribed.
• HORIZANT should be taken once daily with food at about 5 PM.
• If the dose is not taken at the recommended time, the patient should take the next dose at
about 5 PM the following day.
• Tablets should be swallowed whole and should not be cut, crushed, or chewed.
HORIZANT is a trademark of GlaxoSmithKline.
Manufactured by:
Patheon Inc.
Research Triangle Park, NC 27709
For:
Licensed from:
GlaxoSmithKline
Research Triangle Park, NC 27709
XenoPort, Inc.
Santa Clara, CA 95051
©2011, GlaxoSmithKline. All rights reserved.
GEN074R0
April 2011
HZT:1BRS
ADVOCACY IN ACTION
Sports Concussion, Tort Reform Make Headway in State Legislatures
Despite continuing budget troubles which resulted in several
special sessions (and one state government shutdown),
legislatures and assemblies across the country were able to
implement numerous policies supported by the AAN, especially
regarding the issue of youth sports concussion.
The Academy continues to partner with patient groups, state
medical associations, and other physician organizations to
educate legislators about the AAN’s positions. Issues tracked
by the Academy are determined by the Government Relations
Committee, which evaluates state priorities on an annual basis.
The following is a summary of state actions through July 2011.
Visit www.aan.com/advocacy for a more extensive listing of
issues the AAN has been tracking.
Sports Concussion
Fifteen states (Alaska, Arizona, Colorado, Indiana, Iowa, Kansas,
Louisiana, Maryland, Minnesota, Nebraska, North Carolina, North
Dakota, South Dakota, Texas, and Utah) have enacted sports
concussion laws in 2011 with another four awaiting the signature
of the governor as of this writing (Delaware, Illinois, Missouri, and
New York). Assuming those bills are signed, this brings the total
number of states enacting sports concussion laws to 28.
Earlier this year, the AAN joined the National Youth Sports
Concussion Coalition, an organization headed by the American
College of Sports Medicine. Both organizations represented
the coalition at the National Conference of State Legislatures
Summit, which took place in San Antonio in August, to promote
the need to implement sports concussion regulations to
legislators representing states that have yet to act.
Tort Reform
The results of the 2010 elections on state legislatures may have
tipped the scales in favor of medical malpractice reforms.
Many bills, including some putting new caps on non-economic
damages, finally made their way through the legislative process.
Of the 21 bills the Academy was tracking, eight states enacted
new reforms (Florida, Oklahoma, Pennsylvania, South Carolina,
Texas, Tennessee, Virginia, and Utah).
Of note is Texas, which enacted a “Loser Pays” law that says
that a plaintiff must pay the winning party’s legal fees if their
complaint is judged to be groundless. Signed by Governor
Rick Perry in May, the new law should result in fewer frivolous
lawsuits and lower litigation costs. And the North Carolina
legislature overrode a gubernatorial veto of a tort reform bill that
includes provisions that should improve the liability climate in
that state. The new law includes language that limits the amount
of non-economic damages to $500,000.
Stroke
Arizona, Nevada, and South Carolina enacted legislation that
implements new provisions pertaining to stroke protocols.
Of note is what took place in South Carolina, where Governor
Nikki Haley originally vetoed legislation enacting the Stroke
Prevention Act of 2011. However, the legislature was able to
override it, making the bill become law.
The Academy has been working with the American Stroke
Association to help educate legislators on the issue of stroke,
as well as to help appoint stroke experts to task forces and
committees when called for.
Antiepileptic Drugs (AEDs)
The Academy tracked bills in Connecticut, Indiana, Iowa, and
New York related to AEDs in 2011. Iowa passed legislation
that creates a task force studying the AEDs. Progress has been
made in other states, including Indiana, where the state senate
passed legislation that would have required a pharmacist to
alert the prescribing physician and patient when a switch is
made. Unfortunately, the bill did not pass the House before
adjournment. And as of this writing, a bill in Connecticut was
still alive waiting for a vote on the floor. The Academy will
continue its partnership with the Epilepsy Foundation on this
issue moving forward.
ANNUAL MEETING
ANNUAL MEETING
2012 Annual Meeting Set for Historic, Vibrant New Orleans
Now Accepting Applications for 2012 Scientific and Non-scientific Awards
The 64th AAN Annual Meeting is coming to New Orleans
April 21 through 28, 2012. History, architecture, culture, art,
music, literature—and, of course, food—abound in New
Orleans, one of American’s most unique, authentic, and exciting
destinations. Regardless of age, interest, or length of stay, there
are countless ways to explore, indulge, and create lasting
memories in this often referred to as “most European”
of American cities.
golfing, fishing, and other outdoor recreational activities
among the natural beauty of New Orleans.
The AAN is now accepting applications to recognize the next wave of bright minds and their remarkable accomplishments. The 2012
AAN scientific and non-scientific awards will be presented at the 64th AAN Annual Meeting in New Orleans.
Learn more at the New Orleans Visitors Guide at
www.neworleansinfo.com.
Information and application instructions for these prestigious awards are available at www.aan.com/view/2012awards.
Visit the World-famous Historic French Quarter
Early Online Registration Opening in October!
Look to www.aan.com/am beginning in October to take advantage
of early registration discounts to the 2012 Annual Meeting.
More than 100 square-blocks of art, dining, shopping,
entertainment, and architectural treasures abound in the
world-famous French Quarter. Climb aboard a mule-drawn
carriage for a romantic tour of the cobblestone streets.
Take in One—or More—Exciting Walking Tours
•History tours
•Literary tours
•Architectural tours
•Ghost tours
•Movie tours featuring sites from Interview with the
Vampire, The Curious Case of Benjamin Button,
Pretty Baby, and The Pelican Brief
•More
Photographer: Richard Nowitz
Experience World-famous Music Scene and
New Orleans Jazz & Heritage Festival
No city loves music more than New Orleans, and in this city
music abounds from the streets, clubs, churches, concert halls,
and just about everywhere. Consider extending your stay after
the Annual Meeting to take in the famous annual New Orleans
Jazz & Heritage Festival, set for April 27 to May 6. Learn more
at www.nojazzfest.com.
Take a Ride on a Famous Historic Streetcar
Choose from one of three operating streetcar lines in New Orleans;
climb aboard and slide onto one of the wooden seats, and
explore St. Charles Avenue, Riverfront Street, and Canal Street.
Go on a Culinary Journey
Photographer: Carl Purcell
Experience America’s most delicious city and take in all the
smells and flavors of classic New Orleans’ cuisine—seafood,
Cajun, Creole—that make dining a memorable occasion.
Scientific Awards
Applications for all scientific awards are due November 1, 2011.
Contact Erin Jackson at ejackson@aan.com or
(651) 695-2704 to learn more.
Application deadlines and contact information vary.
•AAN Alliance Awards: Founders and S. Weir Mitchell
•Dreifuss-Penry Epilepsy Award
•John Dystel Prize for Multiple Sclerosis Research
•Sheila Essey Award: An Award for ALS Research
•Norman Geschwind Prize in Behavioral Neurology
•Lawrence C. McHenry Award: An Award for the
History of Neurology
•Medical Student Essay Awards:
-- G. Milton Shy Award in Clinical Neurology
-- Saul R. Korey Award in Experimental Neurology
-- Roland P. Mackay Award in Historical Aspects
-- Extended Neuroscience Award
•Movement Disorders Research Award
•Neuroscience Research Prize
•Neuroendocrine Research Award
•Michael S. Pessin Stroke Leadership Prize
•Mitchell B. Max Award for Neuropathic Pain
•Potamkin Prize for Research in Pick’s, Alzheimer’s,
and Related Diseases
•Research Award in Geriatric Neurology
•The Bruce S. Schoenberg International Award
in Neuroepidemiology
•Sleep Science Award
•Jon Stolk Award in Movement Disorders for Young
Investigators
•Harold Wolff-John Graham Award: An Award for
Headache/Facial Pain Research
•Wayne A. Hening Sleep Award for Young Investigators
Clinical Research Training Fellowship
Applications Due October 1
Residents, fellows, and trainees are encouraged to apply for a
Clinical Research Training Fellowship from the AAN Foundation.
Fellowships provide up to three years of salary and protected
time in variety of research areas. Start your application today
at www.aan.com/go/foundation/research.
Immerse Yourself in Unparalleled Culture and Arts
From the Arts District to Magazine Street, New Orleans is
filled with vibrant, diverse neighborhoods alive with galleries,
shopping, dining, and special events all year around.
Explore the Great Outdoors
Discover live alligators and swamp irises in bloom on organized
swamp tours, experience a jazz or harbor cruise on an authentic
paddlewheel boat on the Mighty Mississippi, or simply enjoy
•Kenneth M. Viste, Jr., MD, Neurology Public Policy Fellowship
October 15, 2011 / Mike Amery, mamery@aan.com
or (202) 506-7468
•NEW! Patient Safety Award
November 1, 2011 / Amy Wallace, awallace@aan.com
or (651) 695-2817
•Resident Scholarship to the Annual Meeting
November 1, 2011 / Cheryl Alementi, calementi@aan.com
or (651) 695-2737
•Program Directors Recognition Award
November 1, 2011 / Lucy Persaud, lpersaud@aan.com
or (651) 695-2741
•International Scholarship Award
November 1, 2011 / Franziska Schwarz, fschwarz@aan.com
or (651) 695-2807
•Kenneth M. Viste, Jr., MD, Patient Advocate of the Year Award
November 30, 2011 / Julie Grengs, jgrengs@aan.com
or (651) 695-2755
•AAN Award for Creative Expression of Human Values
in Neurology
December 1, 2011 / Karen Kasmirski, kkasmirski@aan.com
or (651) 695-2731
•Minority Scholars Program
December 1, 2011 / Wendy Vokaty, wvokaty@aan.com
or (651) 695-2714
•H. Richard Tyler Award
December 1, 2011 / Susan Corcoran, scorcoran@aan.com
or (651) 695-2758
•2013 A.B. Baker Award for Lifetime Achievement in
Neurologic Education
January 31, 2012 / Nancy Poechmann, npoechmann@aan.com
or (651) 695-2812
NEW! Education Research Grant Available
to Study AAN CME Programs at
2012 Annual Meeting
A new education research grant of up to $11,500 is available
to Associate or Active members of the AAN to study the
effectiveness of neurologic education programs offered by
the AAN at the 2012 Annual Meeting in New Orleans. The
deadline to apply is October 3, 2011. For more information,
eligibility requirements, and an application, visit
www.aan.com/go/education/eduresearch.
Photographer: Richard Nowitz
15
ANNUAL MEETING
Abstracts Sought for Integrated Neuroscience,
Subspecialty in Focus Programs
The AAN seeks abstracts in key topic
areas to round out scientific programming
at the 2012 Annual Meeting in New
Orleans. Submissions are due October 24,
2011. Integrated Neuroscience Sessions
will be offered in the following areas:
•RNA Metabolism in Neurodegeneration
•Plasticity in Basal Ganglia Therapy
•Biomarkers in Neurologic Diagnosis
and Therapeutic Monitoring
•Stem Cells
•Mitochondrial Diseases in Neurology
•Non-memory Systems in the Brain
•The Essential Role of Neurologists
in Treating and Preventing Stroke
•Pediatric Movement Disorders
•Epilepsy and Channelopathies
•Peripheral Nerve Regeneration
Many of these sessions will be part of the
popular Subspecialty in Focus programs,
which will focus on:
•Aging
•Cerebrovascular Disease
•Child Neurology
•Epilepsy
•Movement Disorders
•Peripheral Nerve Disorders
The AAN also seeks abstracts
for the Future of Neuroscience
Conference: Translational
Neuroscience, a daylong
program featuring platform
presentations, poster sessions,
and invited speakers.
These programs are in
addition to the wide variety of
neuroscience topics for which
abstracts are being sought.
AEI: 2011: Career Week Ad
USAGE: To be exported as High Res PDF for Neurology Journal
SPECS: 8.25"x5.4375": Full bleed +0.125": BW
Submitters should complete the online
form at www.aan.com/go/science for
their work to be considered. Please visit
www.aan.com/go/am12 for a pdf of the
Call for Abstracts. For more information,
contact Erin Jackson at ejackson@aan.com
or (651) 695-2704.
2012 Call for
Abstracts
Many patients treated for MS
still face disease activity
Expect your
patients
to be
64th AAN Annual Meeting
New Orleans
Ernest N. Morial
Convention Center
April 21–28, 2012
Early Registration Deadline
March 28, 2012
 Abstract Submission
 Scientific and
 Preliminary Education
Program
1
Your Next Career Move Starts at Neurology Career Week!
The only FREE job fair specific to neurology
comes to you online, October 10 through 14:
•
•
•
•
•
•
•
OnlineJobFair:chatonlinewithemployers
OnlineJobSearch:hundredsofneurologypostings
C.V.Reviews:submityoursforfeedback
MockInterviews:practiceyourinterviewskillsviaSkype
FREEdailywebinarsonavarietyofimportantcareertopics
DailyAANStoreSpecials
Prizesandmore!
www.aan.com/careers
Someactivitieshavedeadlines.Seewebsitefordetails.
morE activE
than thEir
DisEasE.
Many patients treated for MS still face disease activity
Expect your patients to be
morE activE
than thEir DisEasE.
thErE’s an urgEnt nEED to aDDrEss thE
signs of DisEasE activity
TODAY’S DECISIONS DETERMINE
TOMORROW’S OUTCOMES
Disease activity in patients with MS should be a sign that those patients may not be
responding to treatment. With recurring relapses comes the risk of irreversible damage.1
And, evidence shows that half of patients may experience rapid physical decline once
they reach an EDSS of 4.0. 2 Therefore, it is urgent that immediate action be taken at
the first signs that disease activity is not adequately managed.
Intervening with the right therapy at the right time can make
a significant impact on relapse rates, disability progression,
MRI results, and patients’ quality of life.
signs that inDicatE a patiEnt may not bE rEsponDing
to trEatmEnt can bE mEasurED—anD assEssED
In addition to evaluating annual MRIs and relapses, disease activity can be measured
in-office using multiple validated assessment tools. The timed 25-foot walk and
9-hole peg tests, as well as the MSIS-29 and the SF-36, provide valuable diagnostic
assessments of the physical-, mental-, and quality of life–related effects of disease
progression. These tools make it feasible to document ongoing disease activity
and respond to changes with immediate action before patients experience further
disease progression.
for morE information, plEasE visit www.awareofthemsigns.com
BECAUSE ThEY ShOULD ExpECT TO BE
MORE ACTIvE ThAN ThEIR DISEASE,
YOU ShOULD ACCEpT NOThINg LESS.
ANNUAL MEETING
2012 Preliminary Education Program Available
The preliminary Education Program for the 2012 Annual Meeting in New Orleans is now available. The innovative program will allow
attendees to customize their schedules with a selection of more than 160 programs in general neurology, specialty areas, practice
management, and more. The program’s broad range of topics combine education and science to appeal to all levels of expertise,
and provide a curriculum-based program to specifically meet the needs of neurologists interested in particular topic areas.
“This year, the AAN Annual Meeting will have an exciting lineup of educational offerings,” said Education Committee Chair Cynthia L.
Comella, MD, FAAN. “The program provides opportunities for attendees to participate in a variety of courses related to diverse topics
at differing levels of expertise using varied educational methods. Included in the program will be the popular Morning Reports, clinical
skills pavilions, self-assessment courses, NeuroFlashes, and the didactic review and update courses. Additionally, in collaboration with the
Science Committee and subspecialty societies, there will be six Subspecialty in Focus programs. These will highlight advanced educational
topics combined with a scientific Integrated Neuroscience program in specific subspecialty areas, allowing a concentrated focus on a topic
over a continuous one-and-a-half-day period. Furthermore, the AAN will provide attendees with the opportunity to develop an individual
curriculum of courses and scientific activities to meet their specific needs. I look forward to seeing you in New Orleans!”
For more information about the 2012 Annual Meeting Education Program, contact Amy Nostdahl at anostdahl@aan.com or
(651) 332-8687.
2012 Annual Meeting Education Program Tentative Schedule
Saturday, April 21
A.M. Half-Day Courses / 8:00 a.m.–12:00 p.m.
1AC.001 Resident Basic Science I:
Neuropathology
1AC.002 Deep Brain Stimulation Management
1AC.003 Diagnostic Dilemmas in
Multiple Sclerosis
1AC.004 Neuromuscular Junction Disorders
Education Directors Program /
8:00 a.m.–4:00 p.m.
1EP.001 Clerkship and Program Directors
Conference
Full-Day Course / 8:00 a.m.– 4:00 p.m.
1FC.001 The Practice of Neurology: Issues
in Coding and Reimbursement
P.M. Half-Day Courses / 2:00 p.m.–6:00 p.m.
1PC.001 Peripheral Neuropathy Therapy–
Subspecialty in Focus Program
1PC.002 Resident Basic Science II:
Functional Neuroanatomy
FOR MORE INFORMATION, PLEASE VISIT
www.AwareOfTheMSigns.com
References: 1. Lublin FD, Baier M, Cutter G. Effect of relapses on development of residual deficit in multiple sclerosis. Neurology. 2003;61:1528-1532.
2. Confavreux C, Vukusic S, Moreau T, Adeleine P. Relapses and progression of disability in multiple sclerosis. N Engl J Med. 2000;343:1430-1438.
© 2011
01/11
Kick-Off Programs / 4:00 p.m.–6:00 p.m.
1KP.001 The Neurohospitalist Model: Why,
How, and Implications Thereof
1KP.002 Top 10 Neuro-ophthalmic Diagnoses
You Can't Afford to Miss
1KP.003 Multiple Sclerosis (Quint)Essentials
1KP.004 Recognition and Management of the
Many Types of Status Epilepticus
1KP.005 Surviving Stroke Call: A Guide
for Nonvascular Neurologists
1KP.006 Diagnostic Testing in Neuromuscular
Disease*
1KP.007 Borderlands of Neurology and
Internal Medicine
1KP.008 Assessment of Rapidly Progressive
Dementias and Related Neurologic
Conditions
Sunday, April 22
Morning Report / 6:30 a.m.–8:00 a.m.
2MR.001 Morning Report: Memory Disorders
Neuro Flashes / 6:30 a.m.–8:00 a.m.
2NF.001 Neuro Flash: Sleep Medicine
2NF.002 Neuro Flash: Acute Stroke Management
2NF.003 Neuro Flash: MRI and Multiple
Sclerosis*
Seminars / 6:30 a.m.–8:30 a.m.
2SM.001 Introduction to Genetics
2SM.002 Starting Your Career: The Early Years*
Extended Seminars / 6:30 a.m.–9:30 a.m.
2ES.001 Clinical E-Pearls
2ES.002 EEG In Children: Developmental
Maturation, Variants, Epilepsy
Syndromes, and Identification of
Surgical Candidates
2AC.001 Headaches in Adults I
2AC.002 Child Neurology I
2AC.003 Resident Basic Science III:
Neuropharmacology
2AC.004 Non-Alzheimer's Dementia
2AC.005 Sports Neurology
2AC.006 Emergency Room Neuro-ophthalmology
2AC.007 What’s in a Stroke Center: Members,
Services, Organization and Roles–
Seminars / 9:30 a.m.–11:30 a.m.
2SM.003 Practice Survival for Neurologists:
Business Strategies for Success*
2SM.004 Clinical Grant Writing
Full-Day Courses / 10:00 a.m.–6:00 p.m.
2FC.001 Clinical Epilepsy
2FC.002 Neurologic Intensive Care
2FC.003 Movement Disorders
2FC.004 Therapy in Neurology
2FC.005 Infections of the Nervous System
Skills Workshop / 10:00 a.m.–6:00 p.m.
2SW.001 EMG Skills Workshop: Basic
P.M. Half-Day Courses / 2:00 p.m.– 6:00 p.m.
2PC.001 Headaches in Adults II
2PC.002 Child Neurology II
2PC.003 Autoimmune Neurology
2PC.004 Spine Neuroimaging:
Clinical-Radiologic Correlation
2PC.005 White Matter Disease in Cognitive
Aging–Subspecialty in Focus Program
2PC.006 Inherited Neuropathies: From Bench to
Bedside–Subspecialty in Focus Program
Monday, April 23
Morning Report / 6:30 a.m.– 8:00 a.m.
3MR.001 Morning Report: Multiple Sclerosis
Continued on page 22
3-8196-01
21
ANNUAL MEETING
ANNUAL MEETING
Continued from page 21
Continued from page 22
3NF.001 Neuro Flash: Approach to Acute
CNS Infections
3NF.002 Neuro Flash: Opioid Therapy
for Headache and Neuropathic
Pain Syndromes: Consensus and
Controversies
3SM.001 Mitochondrial Disorders in Neurology
3SM.002 Career Development for
Clinician Educators
3SM.003 Global Health Challenges:
Neurology in Developing Countries
3ES.001 Making Sure Your Electronic Health
Record System Is a Success
3ES.002 Eye Movement Disorders: A Systematic
Approach to the Evaluation of Diplopia
3AC.001 Stroke in Children and Neonates
3AC.002 Clinical Practice Survival Guide
3AC.003 Multiple Sclerosis Overview I:
Basic Science
3AC.004 Sleep for the Practicing Neurologist
3AC.005 Neuro-oncology: Primary Brain Tumors
3AC.006 Vascular Contributions to Cognitive
Impairment and Dementia–Subspecialty
in Focus Program
3AC.007 Emerging Techniques and Directions in
Epilepsy–Subspecialty in Focus Program
3AC.008 Impulse Control Disorders and Reward
Mechanisms in Movement Disorders–
Seminar / 9:30 a.m.–11:30 a.m.
3SM.004 Spine and Spinal Cord Emergencies
3SM.005 Archival Neurologic Films
3FC.001 Genetics in Neurology
3FC.002 Cerebrovascular Disease
3FC.003Neuro-ophthalmology
3FC.004 Peripheral Neuropathy
3FC.005 Neurology Update I
3SW.001 Neurophysiologic Intraoperative
Monitoring
Extended Seminars / 11:00 a.m.–2:00 p.m.
3ES.003 Palliative Care
3ES.004 Improving Accuracy of Dementia
Diagnosis: Case Studies with Both
Imaging and Neuropathology
3PC.001 Bedside Evidence-Based Medicine:
How to Deconstruct Articles in Order
to Take Care of Patients
3PC.002 Multiple Sclerosis Overview II:
Clinical Advances
3PC.003 Continuum ® Test Your Knowledge:
A Multiple-Choice Question Review
3PC.004 Neurologic Complications of
Systemic Cancer
3PC.005Neuropsychiatry–Subspecialty in
Focus Program
3PC.006 Evaluation and Management
of Autonomic Disorders
Tuesday, April 24
4SM.001 Case Studies in Neuro-oncology
4SM.002 E/M: Minimize Mistakes,
Maximize Reimbursement
4SM.003 The Dystonias: Diagnosis, Treatment,
and Update on Causes
4SM.004 Editor's Seminar: Tips for Writing
and Reviewing in Neurology ®
4SM.005 Mild Cognitive Impairment:
Implications for Clinicians
4SM.006 Nystagmus: An Organized Approach*
Neurology Skills Pavilion / 1:00 p.m.–5:00 p.m.
4NP.001 Neurology Skills Pavilion:
Neuromuscular Bedside Rounds
4PC.001 Pain Management Basics: A Primer
for Neurologists
4PC.002 History of Neurology: The Origins
of the Neurological Examination
4PC.003 Cumulative Sports Concussion and
Risk of Dementia
4PC.004 Practical Legal Issues for Neurologists
4PC.005 Epilepsy, Brain Injury, and Cognitive
Costs–Subspecialty in Focus Program
4PC.006Myoclonus–Subspecialty in
Focus Program
Wednesday, April 25
5SM.001Neurotoxicology
5SM.002 Case Studies: Clinical Ethics,
Professionalism, and Evidence-based
Care of Patients with Severe
Life-limiting Neurologic Disease*
5SM.003 Psychogenic Movement Disorders
5SM.004 Brain Computer Interfaces: Frontiers
in Neurology and Neuroscience
5SM.005 The Neurology of Social Behavior
5SM.006 Small Fiber Neuropathies: Somatic,
Autonomic, or a Mixture of Both
5NP.001 Neurology Skills Pavilion:
Neuro-ophthalmology and
Neurovestibular Exam Lab
5PC.001Myelopathies
5PC.002 Neurology Telemedicine Systems
5PC.003 Women's Neurologic Issues
in Pregnancy
5PC.004 Parkinson's Disease and Movement
Disorders Update
P.M. Skills Workshop / 2:00 p.m.– 6:00 p.m.
5PW.001 Acute Stroke Alert Skills Workshop
Thursday, April 26
6NF.00 Neuro Flash: Epilepsy
6NF.002 Neuro Flash: Thunderclap Headache:
The Big, the Bad and the Ugly
6SM.001 Hallucinations in Parkinson’s Disease
6SM.002 What Neurologists Really Need to Know
About Normal Pressure Hydrocephalus
6SM.003 Attention Deficit Hyperactivity Disorder
Across the Lifespan
6SW.001 Advanced Techniques in EMG and
Neuromuscular Disease
6NP.001 Epilepsy Skills Pavilion
6PC.001 Hot Topics in Headaches and
Related Disorders*
Continued on page 23
6PC.002 Clinical EMG I
6PC.003 Neurologic Complications of
Medical Disease
6PC.004 Update on Endovascular Treatment
of Cerebrovascular Diseases
6PC.005Leukodystrophies–Subspecialty in
Focus Program
7AC.004 Botulinum Toxins: Practical Issues and
Clinical Uses for Neurologists
7AC.005 Clinical Issues in Multiple Sclerosis
7AC.006 Traumatic Brain Injury
Case Studies Programs / 6:00 p.m.–9:00 p.m.
6CS.001 Case Studies: Neuroimaging
6CS.002 Case Studies: Multiple Sclerosis
6CS.003 Case Studies: Unusual Movement
Disorders
6CS.004 Case Studies: Unusual Diagnostic
and Management of Cases in
Neuromuscular Disease
6CS.005 Case Studies in Behavioral Neurology
7FC.001 Update in Neuroimaging:
Essentials and Beyond–Part I
7FC.002 Dementia Update
7FC.003 Clinical EEG
7FC.004 Neurology Update II
Friday, April 27
Therapy Programs / 12:00 p.m.–2:00 p.m.
7TP.002 Therapy of Multiple Sclerosis
7TP.003 Therapy of Movement Disorders
Morning Report / 6:30 a.m.–8:00 a.m.
7MR.001 Morning Report: Challenging
Headache Cases
7NF.001 Neuro Flash: Neuro-ophthalmology
7NF.002 Neuro Flash: Child Neurology
7SM.001 Balance and Gait Disorders
7SM.002 Therapeutic Hypothermia*
7SM.003 Vaccines and Neurologic Adverse Events
7SM.004 Differential Diagnosis of Dementia:
Linking Clinical Syndromes
to Biomarkers
7AC.001 Diagnosis and Management
of Leukodystrophies
7AC.002 Clinical EMG II
7AC.003 Sleep Disorders in Clinical Neurology
Therapy Program / 9:00 a.m.–11:00 a.m.
7TP.001 Therapy of Stroke
Neuroscience Conference / 9:00 a.m.–5:00 p.m.
7SC.001 Future of Neuroscience Conference:
Translational Neuroscience
7PC.001Neuro-otology
7PC.002 Primer of Behavioral Neurology
7PC.003 Special Topics in the Neurology
of Sleep
7PC.004 Emergency Neurology
7PC.005 Common Spine Disorders
7PC.006 Neurodevelopmental Disorders–
P.M. Skills Workshop / 1:00 p.m.–5:00 p.m.
7PW.001 Clinical Usefulness of Botulinum
Toxin and Treatment of Dystonia
Therapy Programs / 3:00 p.m.–5:00 p.m.
7TP.004 Therapy of Headache
7TP.005 Therapy of Neuromuscular Disease
Are You Getting Your
AANe-news?
Don’t miss the latest news headlines from your Academy! As an exclusive member benefit,
you should be receiving AANe-news™ the second and fourth Wednesday of each month if
your email address is on file. If not, be sure to set your email filter to accept mailer@aan.com
as a friendly address. Or update your email address at www.aan.com/go/membership.
It’s Not Spam… It’s AANe-news!
Saturday, April 28
8SM.001 Sleep in CNS Disorders
8SM.002 Vascular Cognitive Impairment and
Dementia: Current Status and Future
8SM.003 Pediatric Pseudotumor Cerebri:
From Diagnosis to Treatment
8SM.004 Update on Ataxias
8SM.005 You Make the Call–An Interactive,
Multimedia, Case-Based Approach
to Learning EMG Waveform Analysis
8ES.001 Criteria for Stopping and Starting
Multiple Sclerosis Therapy
8ES.002 Acute Encephalopathy
8AC.001 Update in Neuroimaging: Essentials
and Beyond–Part II
8AC.002 Neuromyelitis Optica:
Scientific and Clinical Update
8AC.003 Consultations in the Medical
Surgical ICU
8AC.004 How to Analyze Spells by Video-EEG
8AC.005 Clinical Approach to Muscle Disease
8AC.006 Psychiatry for the Neurologist
Seminars / 9:30 a.m.–11:30 a.m.
8SM.006 Learning Movement Disorders in
Hindsight: Lessons from My Patients
8SM.007 Common and Important
Ophthalmoscopic Findings*
* Indicates the program has been selected for rotation
Program subject to change. Current as of 8/17
EDUCATION
EDUCATION
Introducing Mobile Neurology CME
Neurology ® CME is now available in a mobile-optimized
version. Mobile Neurology CME helps Neurology journal
subscribers maintain competence, gain up-to-date knowledge,
and learn about best practices and developing issues in the
world’s leading clinical neurology publication. Fulfill your
continuing education requirements on the go.
Features and Benefits of Mobile Neurology CME
Fall Conference Programs Focus on Improving Your Practice’s Bottom Line
supported for either mobile or desktop views. Tablets, including
iPad, will by default display the mobile version of Neurology
CME, but can also display the desktop version if you prefer.
In addition, a mobile version of Neurology for smartphones is
available that is optimized for small screens, works on a variety
of devices, and contains most of the content and features of the
online journal.
•Convenient, portable way to meet your CME requirements
•Newly published CME content is instantly available on your
mobile device
•Your results sync with My CME in the desktop version
•Save your progress if you get interrupted
•Instant feedback on quizzes with automatic scoring
•See highlighted links to the correct answer in context
•Claim credit right on your mobile phone
•Print certificates from My CME when you get back
to your desk
With Neurology CME there is no need to download an app.
Simply access Neurology CME from any supported mobile
device by going to cme.neurology.org. Supported devices
are: iPhone, iPod touch, iPad, and Android devices. Palm OS,
Nokia phones, etc., that have web browsers may still access
Neurology CME; however, the display of Neurology CME may
not be optimized for their screens. Blackberry is supported for
newer devices with touchscreens, but older Blackberries are not
New Features Also Available
in Desktop Neurology CME
The updated Neurology online CME Program still provides a
convenient way to fulfill your CME requirements including:
• Quizzes organized into courses that correspond to one issue
• Evaluation of courses (mandated by ACCME)
• Outlined learning objectives
• Links to highlighted answers in text of article
Now we offer the following enhancements:
• Better visual integration with neurology.org
• Login for personalized browsing of CME courses—see what you
haven’t done
• Search for CME courses by keyword or title word
• Email alerts for new CME courses
• New Mobile CME access information
• Explicit information on state licensure and ACCME guidelines
• Enhanced Help and Instruction links
You may access CME courses via the Neurology CME page.
Links are also provided on the journal home page, on tables
of contents, and on the CME-designated articles themselves.
Learn how to cut through the red tape to
reduce denials, improve your payments,
and increase your practice’s bottom line
at the 2011 AAN Fall Conference, set for
October 21 through 23 at the Encore at
Wynn Las Vegas—a favorite destination
of previous Fall Conference attendees.
Additional talks will include strategies
on avoiding regulatory penalties and
insurance denials.
This year’s Practice Management Track
provides three essential programs
that offer an excellent opportunity to
bring your staff along for additional
training on the latest coding and
reimbursement updates, practical advice
and applications, and tips and tools for
increasing your practice’s efficiency and
getting paid what you deserve.
Friday, October 21
“The complexities governing the provision
of health care today make it impossible
for physicians to survive without strong
guidance,” said Orly Avitzur, MD,
MBA, FAAN, director of the Practice
Management 201 course. “It’s simply a
matter of survival; neglecting the financial
aspects of your business can be simply
disastrous. And if you’re thinking of
leaving practice and joining a hospital
system or large multi-specialty group, as
many neurologists are starting to do, it’s
important to understand the pitfalls of such
alliances and avoid getting the short end
of the stick.”
Program and Faculty:
The Fall Conference’s convenient
weekend program is limited to only a few
hundred participants, making this an ideal
learning environment and providing you
the chance to network with colleagues
and faculty in an intimate atmosphere.
And the conference’s compact, three-day
schedule offers a remarkable value for
maximizing your training and education
budget with minimal impact on your
busy schedule.
Added Avitzur, “We are very fortunate
to have Frank Cohen, MPA, a leading
medical practice analyst and consultant,
share his expertise on improving business
practices this year, and William Henderson,
FACMPE, practice administrator and
member of the Practice Management &
Technology Subcommittee, who recently
negotiated a merger.”
Register for the full Practice Management
Program Track and save 10 percent
instantly.
Practice Management 101: Coding,
Billing and the Document—A CaseBased Approach
8:00 a.m.–12:00 p.m.
CME Credits: 3.5 hours
Director: Bruce H. Cohen, MD, FAAN,
Akron, OH
•The Basics of E/M CPT / Bruce H.
Cohen, MD, FAAN, Akron, OH
•Electronic Communication / Neil A.
Busis, MD, FAAN, Pittsburgh, PA
•Use AAN Guidelines to Avoid
Denials / Gregory L. Barkley, MD,
FAAN, Detroit, MI
Friday, October 21
Practice Management 201: Practicing
in 2012: How to Make Sure You Get
Every Dollar
1:00 p.m.–5:00 p.m.
Director: Orly Avitzur, MD, MBA, FAAN,
Tarrytown, NY
•Learn Six Sigma for the Medical
Practice; Improving Profits by
Improving Processes / Frank Cohen,
MPA, Clearwater, FL
•Mergers and Other Alliances: How
to Avoid Getting the Short End of the
Stick / William S. Henderson, FACMPE,
Albany, NY
•Reduce Insurance Denials: Tips
and Best Practices for Getting Paid /
Orly Avitzur, MD, MBA, FAAN,
Tarrytown, NY
•Avoid Penalties: Dollars and
Incentives / Neil A. Busis, MD, FAAN,
Pittsburgh, PA
Orly Avitzur, MD, MBA, FAAN
Saturday, October 22
Practice Management 301: Hitting the
Jackpot with Practice (Performance)
Improvements
1:00 p.m.–5:00 p.m.
Director: Bryan Soronson, CRA,
FACMPE, MPA, Baltimore, MD
•Establishing/Improving Your
Compliance Program / Mary
McDermott, Baltimore, MD
•ICD 10: Are You Ready? /
Bryan Soronson, CRA, FACMPE, MPA,
Baltimore, MD
•Ancillary Growth Strategies for the
Neurologist / David Evans, Dallas, TX
•Emerging Issues / Faculty
Save Even More When You
Register By September 27
Register by September 27, 2011, to save
on registration and hotel costs. Seating
for the Fall Conference is limited,
so learn more and register today at
www.aan.com/view/fall2011.
For more information, contact Amy
Nostdahl at anostdahl@aan.com or
(651) 332-8687.
The 2011 AAN Fall Conference is
an ABPN-approved program for
maintenance of certification that is geared
toward practitioners, academicians,
residents, fellows, practice managers,
and office administrators.
25
EDUCATION
EDUCATION
The AAN Store Comes to Fall Conference
Continuum Call for Nominations: Editor-in-Chief
If you are planning to attend the Fall Conference, be sure to stop by The AAN
Store® booth and pick up the latest wirebound 2011 AAN Pocket Guidelines.
The Editorial Search Committee for Continuum: Lifelong
Learning in Neurology ® is requesting that AAN members
submit the names of eligible candidates for Editor-in-Chief
of the Academy’s premier self-study continuing medical
education program. Self-nominations or nominations
of other AAN members are encouraged. A position
description, including requirements, is available at
www.aan.com/view/continuumeditor.
Cascino, MD, FAAN; Bruce Sigsbee, MD, FAAN; Cynthia L.
Comella, MD, FAAN; Robert A. Gross, MD, PhD, FAAN; and
Steven P. Ringel, MD, FAAN.
The Editor-in-Chief is responsible for publishing six issues of
Continuum ® a year. The appointment is six years beginning
January 1, 2013, with a six-month transition with the current
editor beginning July 2012. The Editorial Search Committee
members are Robert C. Griggs, MD, FAAN, chair; Terrence L.
For more information, contact Andrea Weiss at
aweiss@aan.com or (651) 695-2742.
Other popular items include Ultimate Review for the Neurology Boards:
Question and Answer Companion, a handy new supplement to the popular
preparatory guide. The new 2012 ICD-9-CM provides the latest coding
updates. If you have registered for the conference’s Dystonia Workshop, you
will want to get a copy of the latest Manual of Botulinum Toxin Therapy for
your convenient reference.
Save yourself shipping costs and visit the store to take home the best tools
and resources for your practice. All items are available at the AAN member
discounted price.
Learn more about the AAN Fall Conference at www.aan.com/view/2011fall.
Please submit current curriculum vitae with a letter outlining
scientific editing experience, a vision for Continuum’s role
within the AAN, and an editorial vision for Continuum by
November 30, 2011. All candidates will be required to
complete an AAN conflicts of interest disclosure.
Submit nominations to:
Missy Render, AAN Enterprises, Inc., 1080 Montreal Avenue,
St. Paul, MN, 55116
OTHER NEWS
Two-day Evidence-based Medicine Training Program Now Provides CME
The AAN is again offering its comprehensive Evidence-based
Medicine Toolkit training seminar for neurology program directors
to enable them to establish evidence-based medicine resident
education programs at their institutions. And the Academy—one of
the leaders in the development and promotion of evidence-based
clinical guidelines—is encouraging practicing neurologists and
other medical educators to learn how they can put the principles
of evidence-based medicine to work in their practices or physician
training programs.
•Day 2 is split into three breakout
sessions designed to provide more
in-depth understanding in each of
three areas: Analytic Techniques,
Clinical Trials, and Theory and
Practice. Each breakout session will
be comprised of three modules, and
each session will be presented in the
morning and again in the afternoon.
For the first time, the Evidence-based Medicine (EBM) Toolkit training
will provide continuing medical education credits. The EBM Toolkit
training will take place on October 14 and 15 in Washington, DC,
and the two-day session is worth 13 CME credits.
The opportunity to earn CME credits,
and the flexible structure of the
Gary Gronseth, MD, FAAN
program, adds considerable value to
this training. Attendees can attend one
or two days, and receive eight credits
for the first day and five credits for the second.
More than 50 percent of US neurology program directors have
experienced the EBM Toolkit training, which provides all the
resources necessary for teaching a comprehensive EBM program.
It consists of 19 didactic modules with illustrative examples,
outcomes testing for determining learning, and an appendix
of calculators of tools. The training demonstrates completion
of ACGME core competencies. AAN staff and the EBM expert
faculty are available to provide follow-up and assistance to help
implement the program.
Although the course was developed for resident education,
the learning material is appropriate for anyone in a neurologyrelated field. This EBM training also is valuable for program
directors, department chairs, and medical statisticians in
psychiatry and neurosurgery—as well as educators at medical
schools or teaching hospitals, and AAN members are urged
to encourage their colleagues in these areas to attend.
“The Evidence-based Medicine Toolkit enables neurologists to
combine current best practices with new research to provide the
best patient care,” said Gary Gronseth, MD, FAAN, the Academy’s
evidence-based medicine consultant. “It is difficult to imagine a
more essential skill set for effectively practicing medicine.”
Registration is free for AAN member program directors and
$600 for other AAN members. The fee for nonmembers is
$750. Registration for the training is open until September 30.
Meals will be provided during the sessions. Travel and lodging
are the responsibility of the attendee.
The program is structured to accommodate participants’
training needs:
To register, visit www.aan.com/education/ebm. For more
information about the EBM Toolkit or training, contact Rebecca
Penfold Murray at rpenfoldmurray@aan.com or (651) 695-2735.
•Day 1 provides training on the 10 core modules that
encompass all the basic concepts of EBM and can be easily
presented in the course of an academic year.
UCNS Practice Tracks in Headache Medicine and Behavioral Neurology
& Neuropsychiatry Set to Expire in 2012
The last chance to apply for Headache Medicine or Behavioral
Neurology & Neuropsychiatry certification from the United
Council for Neurologic Subspecialties (UCNS) without
graduating from a UCNS-accredited fellowship program is 2012.
exam will be offered the week of October 1 through 5.
The application deadline for the Behavioral Neurology &
Neuropsychiatry is May 15; the exam will be offered
the week of November 5 through 9.
Initially, physicians applying for UCNS certification examinations
are able to apply using one of two eligibility pathways. The first
is graduation from a UCNS-accredited fellowship program. The
second is via the practice track, which allows physicians who
started with the subspecialty prior to the availability of accredited
training programs to qualify for the examination by meeting a
defined series of criteria.
Beginning in 2014, only physicians graduating from UCNSaccredited training programs in these subspecialties will be
eligible to apply for these exams.
The exams offered in 2012 for Headache Medicine and
Behavioral Neurology & Neuropsychiatry will be the final
exams for which a physician may apply using the practice track.
Applications will be available in early 2012. The application
deadline for the Headache Medicine exam is April 16; the
Get Your Daily Dose of
Academy and Neurology News at
AAN.COM
For more information, visit www.ucns.org or contact
Todd Bulson at tbulson@ucns.org or (651) 695-2813.
FOCUS ON PRACTICE
FOCUS ON PRACTICE
New ICD-9 Codes Affect Neurologists Beginning October 1
Neurologists should prepare for new ICD-9-CM
codes that will go into effect October 1, 2011. There
are several new codes listed below that will affect
neurology, particularly with regard to headache and
migraine, dementia, and epilepsy.
and ICD-10 code sets to capture new technology
and new diseases.
“There will be no further changes to ICD-9-CM
diagnosis codes except for new diseases with
public health implications,” said Powers. “After the
October 1, 2011, update to ICD-10-CM, there also
“The changes to ICD-9-CM beginning October 1
will be a hold on any changes to that classification
reflect to some extent the changes the AAN has
until October 1, 2014. We at the AAN have worked
been seeking for ICD-10-CM with the assistance
diligently at tweaking ICD-10-CM before the
of AAN sections and neurology subspecialty
upcoming October 1 freeze, as that is the version
organizations,” said Laura B. Powers, MD, FAAN.
of the classification that will replace ICD-9-CM on
“In addition to a specific code for brain death, we
Laura B. Powers, MD, FAAN
October 1, 2013. With both classifications ‘frozen,’
also have a new code for corticobasal degeneration.
we at the AAN can concentrate on getting the
The codes for Lambert-Eaton syndrome have
membership
ready for ICD-10-CM implementation in 2013.”
been changed to reflect those not associated with neoplasm.
‘Refractory’ is now officially synonymous with ‘intractable’
in the fifth digits for migraine codes.”
A major victory for neurology was the revision to the title of
Chapter 5 from “Mental Disorders” to “Mental, Behavioral and
Neurodevelopmental Disorders.” This is a considerable change
that will bring more awareness that diagnoses such as dementia
are not “mental disorders” but rather neurologic diseases with
organic causes.
This is the last regular, annual update to both ICD-9-CM and
ICD-10-CM. There will be what is considered “a partial code
freeze” until the implementation of ICD-10 on October 1, 2013.
Until that time, there will be only limited code updates to ICD-9
For more information, contact Luana Ciccarelli at
lciccarelli@aan.com or (651) 695-2779.
November AAN Webinar to Explain
Transition to ICD-10
“ICD-10: What You Need to Know for 2012,” set for November 8,
will help demystify the upcoming changes to the ubiquitous coding
manual. Participants will learn to choose the appropriate diagnosis
code for a service, become aware of the mechanics of the system
and its updates, begin preparing for ICD-10-CM implementation,
and identify the differences between ICD-9-CM and ICD-10-CM.
Visit www.aan.com/go/practice/coding/conferences
to learn more.
New subcategory
294.2 Dementia, unspecified
Excludes: mild memory
disturbances, not amounting
to dementia (310.89)
New code
294.20Dementia, unspecified, without
behavioral disturbance
Dementia NOS
New code
294.21 Dementia, unspecified, with
behavioral disturbance
Aggressive behavior
Combative behavior
Violent behavior
Use additional code, where
applicable, to identify: wandering
in conditions classified elsewhere
(V40.31) New code
310.81 Pseudobulbar affect
Involuntary emotional
expression disorder
Code first underlying cause,
if known, such as:
Amyotrophic lateral sclerosis
(335.20)
Late effect of cerebrovascular
accident (438.89)
Late effect of traumatic brain
injury (907.0)
Multiple sclerosis (340)
New code
310.89 Other specified nonpsychotic
mental disorders following
organic brain damage
Mild memory disturbance
Other focal (partial) organic
psychosyndromes
Postencephalitic syndrome
Excludes: memory loss of
unknown cause (780.93)
346Migraine
The following fifth-digit subclassification
is for use with category 346:
0 without mention of intractable migraine
without mention of status migrainosus
New (without mention of refractory
migraine without mention of status
migrainosus)
1 with intractable migraine, so stated,
without mention of status migrainosus
New (with refractory migraine, so stated,
without mention of status migrainosus)
2 without mention of intractable migraine
with status migrainosus
New (without mention of refractory
migraine with status migrainosus)
3 with intractable migraine, so stated,
with status migrainosus
New (with refractory migraine,
so stated, with status migrainosus)
Also of importance is the new code to be
used for Brain Death:
New Code
348.82 Brain Death
Proposed 2012 Medicare Physician Fee Schedule
Includes AAN Quality Measures
The proposed Medicare Physician Fee Schedule (MPFS) for 2012
issued by the Centers for Medicare & Medicaid Services (CMS)
in July includes quality measures developed by the AAN for
epilepsy, dementia, and Parkinson’s disease.
proposes that the AMA Relative Value Update Committee (RUC)
investigate whether evaluation and management (E/M) codes as
well as the highest volume and dollar procedural codes billed by
physicians are appropriately valued.
“The AAN worked hard to ensure these measures were added to
the program and will urge CMS to adopt their proposed inclusion
of the measures as final for 2012,” said Neil A. Busis, MD,
FAAN, chair of the AAN’s Medical Economics and Management
Committee. “The addition of the measures into the program will
give neurologists the best opportunity to participate.”
The AAN is working diligently to move broader payment and
policy discussion towards recognition and appropriate valuation
of cognitive services (E/M) over procedural care.
The MPFS, which also updates payment policies and rates for
physicians and non-physician practitioners, reflects current
law under which providers would face steep across-the-board
reduction in payment rates, based on the flawed Sustainable
Growth Rate (SGR). If Congress does not act this year to suspend
the reduction, Medicare payment rates are expected to decrease
by 29.5 percent in 2012.
“The AAN feels the SGR is flawed in many ways and needs
to be replaced,” said Busis. “Congress is looking to physicians
and specialty societies for ideas on how to fix the flawed SGR.
The AAN has provided initial thoughts to policymakers and
continues to work to develop a fair and workable solution
to this well-recognized problem.”
In a statement released by CMS Administrator Donald M.
Berwick, MD, said, “This payment cut would have serious
consequences and we cannot and will not allow it to happen.
We need a permanent SGR fix to solve this problem once and
for all. That’s why the president’s budget and his fiscal framework
call for averting these cuts and why we are determined to pass
and implement a permanent and sustainable fix.”
In an effort to ensure Medicare is paying accurately for physician
services and more closely managing the payment system, CMS
CMS is also proposing:
•To expand its multiple procedure payment reduction
to the professional interpretation of advance imaging services
to account for overlapping activities that go into valuing
these services.
• Criteria for a health risk assessment (HRA) to be used in
conjunction with Annual Wellness Visits (AWVs), for which
coverage began January 1, 2011, under the Affordable Care Act.
•To change the way services are added to the approved
telehealth list that would allow requestors to provide
evidence of the clinical benefit of the service.
•To update a number of current physician incentive programs
such as the Physician Quality Reporting System (PQRS), the
e-Prescribing Incentive Program and the Electronic Health
Records Incentive Program.
CMS also proposes quality and cost measures that the agency
would use in establishing a new value-based modifier to reward
physicians for providing higher quality and more cost-efficient care.
More than 1 million providers of vital health services to Medicare
beneficiaries are paid under the MPFS. CMS projects that total
payments under the MPFS in CY 2012 will be $80 billion.
CMS accepted public comments up to August 30, and will
review and respond to all comments in a final rule to be issued
around November 1, 2011.
Key Deadline Nears for EHR Incentive Program
Practicing neurologists only have one month
left to register for the 2011 Medicare Electronic
Health Record (EHR) Incentive Program. Through
successful reporting over a five-year period,
neurologists using a qualified EHR are eligible
for up to $44,000 through the Medicare
incentive program.
“There is no doubt that the practice of medicine is
going to require the use of electronic health records
as we go forward,” said Steven J. Zuckerman, MD,
FAAN. “While the implementation process will
inevitably present some challenges (like any
changes to a comfortable routine) the results are
gratifying in regards to improving care. Adopting
an EHR and demonstrating Meaningful Use is a
process that all physicians will need to accomplish.
Proving adherence to the regulations by attestation
this year is a relatively easy process. Why not
bite the bullet now and have three months of use
count as an entire year for incentive monies—
worth upwards of $18,000. This will be the only
window of opportunity for such a good deal with
government reimbursement.”
Visit www.aan.com/go/practice/pay/ehr to learn
more about the program and access important
resources and tools, including ratings of vendors
and EHR systems provided by the AAN’s new
partnership with AmericanEHR Partners.
Steven J. Zuckerman, MD, FAAN
29
FOCUS ON PRACTICE
MEMBERSHIP
Registration Ends September 16 for New Webinar on Negotiating
with Hospitals and Insurers
Negotiating with hospitals and insurers can be a
touchy topic. The latest AAN Practice Management
webinar “Win, Lose, or Draw? Negotiating with
Hospitals and Insurers,” helps members understand
the pitfalls and gives expert advice to prepare for this
sometimes challenging area of practice.
The 90-minute webinar scheduled for Tuesday,
September 20, at 12:00 p.m. ET provides physicians
1.5 AMA PRA Category 1 Credits™, and nonneurologists receive a certificate of completion
redeemable for credits. The deadline to register
is September 16.
for a negotiation. We also will discuss how to
conduct a negotiation.”
In addition, the program will teach participants
how to use the AAN’s Insurer Relations Toolkit and
other valuable resources to manage the negotiating
process. Kaufman is chair of the AAN’s Payment
Policy Subcommittee and a member of the Medical
Economics and Management Committee.
“Negotiating is difficult for some individuals as they
do not have a process to prepare and present to the
Joel M. Kaufman, MD, FAAN
other side,” said Kaufman. “Physicians, in particular,
do not seem to take the modest amount of time
Program Director Joel M. Kaufman, MD, FAAN, will help
to build their case or develop a long-term strategy to achieve
participants understand how to effectively negotiate with
their goals. This webinar will give some practical tools that will
private insurers and hospital management as well as build
build confidence.”
and maintain positive and productive relationships with these
Registration ends soon; visit www.aan.com/go/practice/coding/
insurers and hospitals.
conferences to sign up now. Members save on remaining
“The biggest risk of not being prepared is leaving money on
webinars in the series when they sign up for more than one
the table or not receiving benefits for work or effort that you
using their member discount.
are already doing,” said Kaufman. “Webinar attendees will learn
For more information, contact Christi Kokaisel at
more about what to do, rather than what to avoid. Preparation is
key, and we will review several approaches on how to prepare
ckokaisel@aan.com or (651) 695-2810.
Neurology Career Week Brings Job Opportunities, Resources to Members
Residents, fellows, graduate students, and anyone looking
to make a career change are encouraged to participate in
Neurology Career Week, a new online event October 10
through 14. This exclusive AAN event is the only career fair
specific to neurologists and neurology-related positions.
The event is free for members who can participate by
creating an online profile in the Neurology Career Center at
www.aan.com/careers. Visit the website for the latest details
and current week’s schedule. Activities for the week include:
•Online Job Fair—Visit virtual booths and chat with an array
of employers seeking neurologists
•CV Reviews—Submit your curriculum vitae before October
11 to be reviewed by experienced AAN members who can
give you feedback on how to improve your résumé
•Mock Interviews—Schedule a face-to-face video interview
via Skype to practice your interview skills and get advice
on presenting yourself during a real interview, email
careers@aan.com by October 7
•Daily AAN Store Specials—Each day a new item from the
AAN Store will be offered at a special rate in addition to
your member discount
•Online Job Search—Look for your next career opportunity
on the world’s largest job search site for neurologists
Olson to Be Honored by AMA
Former AAN President Sandra F. Olson, MD, FAAN, will be presented with the Distinguished Service
Award by the American Medical Association during the opening session at its Interim Meeting on
Saturday, November 10 through 12, 2011, in New Orleans.
According to the AMA, the Distinguished Service Award is bestowed upon AMA members for meritorious
service in the science and art of medicine.
“I feel very honored by this award,” said Olson, “and I wish to thank the Academy for supporting my
nomination for it. I have always found participation in medical society activities rewarding, fulfilling,
and downright fun.”
Learn about these exciting events for job seekers by visiting
www.aan.com/careers today.
Olson served as AAN president from 2003 to 2005 and is the first—and only—woman to hold this
position in the Academy. She also was the first woman to chair the AAN Foundation, serving from 1999 to
2000. She also served on the AAN Board of Directors and numerous Academy committees. She has been
active in many other organizations including the Accreditation Council for Graduate Medical Education,
the American Medical Association Council on Medical Education, the Illinois State Medical Society where
she served as president from 1996 to 1997, and the Chicago Medical Society where she was president
from 1993 to 1994. She was a longtime attending physician with Northwestern Memorial Hospital in
Chicago and professor of clinical neurology at Feinberg Medical School of Northwestern University.
Residents, fellows, and post-doctoral graduates are encouraged to
prepare in advance for Neurology Career Week. Here are a few tips:
1. You must be an AAN member to create a free Career Center
profile. If you are not yet a member, visit www.aan.com/go/
membership/join or talk with your program director.
2. Polish your CV and send it to www.aan.com/careers before
October 11 to be reviewed by an experienced AAN member.
3. Mark your calendar for the week of October 10 so you can
make the most of your time garnering advice, meeting
potential employers, and searching for jobs online.
In addition, Neurology Career Week will also host four free
webinars for neurology professionals, including:
•Monday: “Transition from J1-Visa to Working Visa,” for
international physicians
•Tuesday: PRMS Risk Management Services, Inc., will provide
a comprehensive overview of risk management for residents
and fellows entering the field
•Wednesday: Hospital Corporation of America explain how
the HCA stipend program works, a one- to two-year career
opportunity for residents
•Thursday: “Employment Contracts: What You Should Know”
will offer solid advice for job seekers negotiating their first
contract
MEMBERSHIP
Career Checklist for Neurology Trainees
Win Prizes When You Create Your
Career Center Profile
Visit the Career Center during Neurology Career Week and
you could win an iPad 2 or a Resident & Fellow Career Kit
which includes a Queen Square Hammer, Lanska edition; a
2011 AAN Pocket Guidelines, and an Ultimate Review for the
Neurology Boards book. All profiles created or updated between
September 1 and October 14, 2011, are automatically
entered and eligible to win!
Sandra F. Olson, MD, FAAN
Call for Volunteers for Neurology’s Abstract Translation Project
In order to provide readers worldwide with information about articles in Neurology ®, the journal soon will begin publishing
translations of abstracts in multiple languages.
Neurology is seeking volunteers, including translators and reviewers of translations, to assist with this new abstract translation project.
Each abstract translation will be attributed to the translator and be indexed along with the main journal article on the neurology.org
website. Translated abstracts will be accessible as a link to the online article and also available in language-specific online collections.
To volunteer for this project or for more information, visit www.neurology.org or contact Lee Ann Kleffman at
journal@neurology.org or (651) 695-2782.
31
MEMBERSHIP
FOUNDATION
New Recruitment Concierge Service Assists in Finding Job Candidates
Foundation Friends
With many practices struggling to fill positions—that can take more than a year to recruit—the AAN’s Neurology Career Center now
offers a new job candidate review service to help streamline the process for busy practices of all sizes. The Recruitment Concierge Service
handles the bulk of the workload by writing an advertisement based on your criteria, responding to inquiries and reviewing resumes.
The AAN Foundation greatly appreciates gifts and pledges received from the following donors between June 1
and June 30, 2011. Cumulative annual gifts and pledges of $1,000 or more are recognized as Champions Circle
members, and gifts and pledges of $100 and greater are recognized as Foundation Friends in AANnews ®.
You have the option of choosing from a variety of online and print advertising options.
For secure online giving options, visit www.aan.com/foundation/donations. For more information about the
AAN Foundation programs, contact Susan C. Dunlop at sdunlop@aan.com or (866) 770-7570 Ext. 2701.
The concierge is a vetted service partnering with the Academy that is knowledgeable in hiring the best qualified candidates for the
job. As a member-only benefit you can put the service to work in filling your practice’s open positions for only $1,500, where a
comparable service will usually start around three times as much. The fee is flat and no commission is involved.
“I am proud to join with the AAN Foundation to support
research addressing the striking disparities in neurological
disease burden among minority populations. Once again, the
Foundation is making it possible for gifted neurology trainees
and those just out of training to dedicate themselves to critically
needed research. The Calvin Calhoun, Sr., MD, Minority
Scholars Diversity Research endowment is a high impact
initiative which will create new knowledge in stroke and other
neurologic diseases with disparate risks, characteristics, and
outcomes in the minority communities they afflict.”
For more information, visit the Neurology Career Center at www.aan.com/careers or contact Amy Schoch at aschoch@aan.com
or (651) 695-2749.
New AAN Headquarters Site Gets Visit from Obama Administrator
The building site of the new AAN headquarters in Minneapolis
received a visit from a representative of the Obama
administration on August 8. Frank P. DiGiammarino III, Director
for Recovery Implementation for the White House, examined
the steel framework and fresh concrete floors of the five-story
building with AAN Executive Director Catherine M. Rydell, CAE;
Chief Finance Officer Tim Engel; and executives from Mortenson
Construction, the contractor for the project. DiGiammarino
has been on a nationwide tour of building projects that have
benefitted from bonds funded through the American Recovery
and Reinvestment Act of 2009.
The total cost of the AAN project including land, building
construction, office furniture, and professional fees are $20
million. The Academy’s new building was funded using $15
million in City of Minneapolis Recovery Zone Facility Bonds,
which are designed to encourage capital investment and are
funded through the American Recovery and Reinvestment Act
of 2009. The balance was provided from Academy reserves. The
AAN Board of Directors took steps to set aside annual operating
reserves over the last five years to support the ownership of a
building for the current staff and programs and to better serve
the future growth of the Academy.
Dawn McGuire, MD, FAAN
AAN Member since 1995
Annual Fund
($1,000–$4,999)
Steven L. Lewis, MD, FAAN+*
John C. Morris, MD, FAAN+*
John G. Nutt, MD, FAAN+*
Executive Director Catherine M. Rydell, CAE, greeted Frank P. DiGiammarino III
at the building site.
($500–$999)
Gregory L. Barkley, MD+
Lisa M. DeAngelis, MD, FAAN+
Stanley Fahn, MD, FAAN+
Edward J. Fox, MD, PhD, FAAN+
J. Clay Goodman, MD, FAAN+*
Daniel B. Hier, MD, MBA, FAAN+
Janice M. Massey, MD, FAAN+
Suzanne Powell, MD+
Kapil D. Sethi, MD, FRCP (UK), FAAN+
S.H. Subramony, MBBS, FAAN+
($100–$499)
Michael E. Batipps, MD, FAAN
Patricia S. Cook, MD, FAAN
Edward S. Cooper, MD
Deborah I. Friedman, MD, FAAN+
Robert C. Galbraith, MD
Victor W. Henderson, MD, FAAN+
Peter B. Kang, MD+
Jayne Ness, MD+
Joseph E. Safdieh, MD+
Frederick J. Samaha, MD, FAAN
Adeline Vanderver, MD+
Bradley V. Vaughn, MD, FAAN+
David Graham with ESG Architects, Inc. (left) joined Rydell
and DiGiammarino on the fourth floor of the structure. In the
background are a section of the historic grain mills and the
blue-clad Guthrie Theater, with the Mississippi River behind them.
The building from the front corner. The Hubert H. Humphrey
Metrodome can be seen a few blocks away.
The Fund For Brain Research
Provides Clinical Research Training
Fellowships to the Most Qualified Applicants
($500–$999)
Anonymous*
Jasper R. Daube, MD, FAAN+
J. Clay Goodman, MD, FAAN+
Anthony E. Lang, MD, FAAN+
John M. Pellock, MD, FAAN+
($100–$499)
Anonymous
Arthur K. Asbury, MD, FAAN
(In memory of Raymond D. Adams, MD)
Edward Feldmann, MD+
Omar A. Khan, MD, PhD+
Aaron E. Miller, MD, FAAN+
John C. Morgan, MD, PhD+
Jayne Ness, MD+
AAN Residents Fund
($1,000–$4,999)
Jóse Biller, MD, FAAN, FACP, FAHA+*
Cynthia L. Comella, MD, FAAN+*
Aaron E. Miller, MD, FAAN+*
($500–$999)
Konstantin E. Balashov, MD, PhD+
Nicolaas I. Bohnen, MD, PhD+
John Corboy, MD, FAAN+
Robert J. Fox, MD, FAAN+
Mark W. Green, MD+
Dara G. Jamieson, MD+
Ralph F. Józefowicz, MD, FAAN+
Jaffar Khan, MD+
James B. Leverenz, MD+
Ann N. Poncelet, MD+
Bryan E. Tsao, MD+
Elaine C. Wirrell, MD+
($100–$499)
Charles H. Adler, MD, PhD, FAAN+
James Y. Garbern, MD, FAAN+
Christopher Glisson, DO+
Mark Keegan, MD+
Coleman Martin, MD+
Jayne Ness, MD+
C. Warren Olanow, MD, FAAN+
Gerald Raymond, MD+
Joseph E. Safdieh, MD+
Nancy L. Sicotte, MD, FAAN+
Scott S. Zamvil, MD, PhD, FAAN+
Alzheimer’s Research Fund
($500–$999)
Anonymous*
MS Research Fund
($100–$499)
John W. Rose, MD, FAAN
Neuro-Infectious Disease Research
($500–$999)
Russell E. Bartt, MD, FAAN+
Avindra Nath, MBBS, FAAN+
Calvin L. Calhoun, Sr., MD, Minority
Scholars Disparity Research
Permanent Endowment
($1,000–$4,999)
Charles C. Flippen II, MD, FAAN*
Edgar J. Kenton III, MD, FAAN*
Dawn McGuire, MD, FAAN*
($100–$499)
John and Susan Dunlop, MBA, CFRE
* Denotes 2011 Champions Circle member
+ Denotes Honoraria Donor
33
Formerly:
Visit the AAN’s new Neurology Career Center online at www.aan.com/careers for additional
job postings and to sign up for customized, confidential notifications when new positions of
interest are added.
www.aan.com/careers
Physician-Owned Multi-Specialty Group near Boulder,
Colorado Longmont Clinic, a physician-owned multi-specialty
group with more than 50 physicians representing 20 specialties, is
seeking two General Neurologists. This is an outstanding quality
of life opportunity that will allow you build a thriving neurology
practice. You will be employed by Longmont Clinic and will practice
at a state-of-the-art, 183-bed community hospital, which resembles
a world class hotel. Longmont, Colorado, located within Boulder
County, is known as the gateway to Rocky Mountain National
Park. With a population of over 85,000 and a medical service
area of over 350,000, this community offers more than 300 days
of sunshine, spectacular views of the Rocky Mountains, outstanding
schools and state-of-the-art health care. Contact Kim DeBlasi at
(800) 678-7858 x64558; kdeblasi@cejkasearch.com; or visit
www.cejkasearch.com. ID#134904DE.
Neurologist Altru Health System located in Grand Forks, North
Dakota is a physician led, not-for-profit, 277-bed integrated health
system. More than 180 physicians representing 44 specialties serve
Altru’s referral population which exceeds 225,000 people. Altru’s
affiliation with the University of North Dakota School of Medicine
allows our physicians exposure to teaching opportunities. We are
a Level II Trauma Center designation. Grand Forks is a Midwestern
community of 65,000. Besides the warm friendliness of its residents,
you will find excellent school systems, safe neighborhoods, low crime
rates, affordable housing and an abundance of cultural and
recreational activities. Premiere neuroscience group in the region
guaranteeing a busy practice with interesting pathology. Full EEG and
EMG services provided. Multiple Sclerosis Specialty Clinic on-site.
Pediatric work available. Committed team of 3 Neurologists and 2
mid-levels. Jenny Semling, Physician Recruiter, Altru Health System,
(800) 437-5373 ext 6607; Fax: (701) 780-6641. jsemling@altru.org
General Adult Neurology Hospitalist - CT and MR reading
privileges Anderson, South Carolina. BC/BE adult neurologist
for in-house coverage week days for consults and ED call for
acute stroke and intraparenchymal bleeds. A neuro-intensive
specialist with interest in stroke is important; medical director
needed. Employment model with competitive RVU-based
compensation; generous benefits including malpractice and CME
allowance. CT and MRI reading privileges. 461-bed medical
center of 578-bed AnMed Health System. NICU and 45-bed rehab
hospital. Stroke Center of Excellence. One medical-system city
serves an area approaching 400K. Level two trauma center; local
hospitalist group; FM residency; cancer center; heart and
vascular center. Anderson is on 50,000-acre Lake Hartwell and
I-85, thirty miles from Greenville. Only two hours to Charlotte,
Atlanta or Columbia. And a morning`s drive to Charleston.
Email sherry.chastain@anmedhealth.org
Neurologist (MS Specialist) - Charlotte NC The Neurology
Department at CMC is seeking a Neurologist, specializing in MS
to join their high caliber team of faculty providers and well-known
MS Center. Qualified candidates will be BC/BE in Neurology with
extensive experience in treating MS. Ideal candidates will be
ACGME fellowship trained in MS and have an interest in education
and research. The MS Center offers state-of-the-art resources
along with an active clinical research program supported by 10
research coordinators and assistants. The clinical staff includes
on-site nurses, physical therapists, occupational therapists, speech
therapists, social workers and a dietician. CMC Neurology offers an
attractive hybrid model of private practice and academics. The
Neurology faculty has the flexibility to see patients in physically
attractive clinic, teach residents and medical students, and participate
in clinical research. The MS Center is situated near uptown Charlotte
in a beautiful residential area. Carolinas HealthCare System (CHS) is a
not-for-profit, self-supporting public organization. It is the largest
healthcare system in the Carolinas, and one of the largest public
systems in the nation. Charlotte, NC is a growing and vibrant city
and is 2 hours from the mountains of NC and 3-4 hours from the
beaches of NC and SC. To send a CV for consideration, please
contact: Tracey Black, Physician Recruiter, P (704) 355-0159/
(800) 847-5084; tracey.black@carolinashealthcare.org
BC/BE Neurologists Upstate New York - Adirondack Mountains
– Lake Champlain Region. CVPH Medical Center (www.cvph.org)
seeks two BC/BE neurologists to join its medical staff. Candidates
with a particular interest in stroke medicine is a plus. Enjoy being a
hospital employee with a comprehensive benefit package and call
of 1:3. Competitive salary with productivity incentive, sign-on and
loan repayment. Big hospital, small city on Lake Champlain, near the
Adirondack Mountains, the Olympic-Lake Placid region, Burlington,
VT, and Montreal. Contact: Rebecca Larkin (rlarkin@cvph.org)
75 Beekman St., Plattsburgh, New York 12901, (518) 314-3025,
Fax: (518) 562-7012
Neurologist Dean Clinic, a 450+ physician-owned multi-specialty
group, is seeking a general Neurologist. A strong interest and
expertise in EMG is required. A fellowship in Neurophysiology is
ideal, but not required. Call is shared with all of the Neurologists in
the Department and is thus 1/10. The position is based in Madison,
but all Neurologists do six outreach clinic days per month throughout
the Dean system. The Department of Neurology is located in a
medical office building that is connected to St. Mary's Hospital, a
350-bed tertiary care facility. There is a guaranteed two-year salary
and signing bonus, plus an outstanding fringe benefits package.
This is a shareholder track position and shareholdership is available
after two years. Email christopher.kashnig@deancare.com
Neurology in Atlanta, Georgia Atlanta, Georgia neurology. Our
three facility system is in the process of expanding its neurology
services by adding a new physician. Join existing hospital employed
practice, full practice from day one. 1-7 phone call, (4 nights a
month). Once again hospital Employed position. Current practice has
the majority of the market in our part of Atlanta proper, EMG/nerve
conduction on site, Hospitalist does admits thru the ERs, some
nerve blocks and carpel tunnel injections, interest in stroke is a plus,
EEG's in the hospital. Atlanta is home to the busiest airport in the
world. Birthplace of Martin Luther King Jr., and the civil rights
movement. Headquarters for Delta Airlines, Coke, CNN, TBS,
Holiday Inn, UPS, Johnson products. Atlanta Hawks, Braves Falcons,
pro sports. Give me a call for all the details. Phone: (404) 816-1801.
Employer will assist with relocation costs.
General Neurologist NYU New York City, midtown, private
practice with a neurologist and three physiatrists. Requiring to join
NYU faculty and applying privilege at NYU medical center. Out
patients care, preferring having experience of treatment for
Parkinson’s disease, pain management and general neurologic out
patient care, including EEG, EMG, VNG, sleep specialty plus. No
partnership available, start with salary ($160K) with late bonus
production, benefit including two week vacation, one week paid
CME, health insurance and 401K. Email xiaoke_gao@yahoo.com
Neurology Opening in Central Massachusetts Opportunity for
a BE/BC Neurologist to join Fallon Clinic’s group of 5 Neurologists
and 1 NP. Office hours are Monday - Friday with 1:6 call on weekends
and 8-9 weeks/year for inpatient weekday call. On average 12-20
patients are seen a day. Some teaching responsibility. Interest in
Multiple Sclerosis and/or Carotid Ultrasonography is a plus.
Competitive compensation and benefits. Fallon Clinic leads central
Massachusetts in quality of care, consistently scoring above
average on the Massachusetts Quality Health Partners quality
report. For more information or to apply, contact Jennifer Sonneland
at (800) 562-9034 or jennifer.sonneland@practicematch.com.
Neurologist First Coast Cardiovascular Institute is adding
neurologists to help it fulfill its mission of serving the cardiovascular
needs of the residents of the greater Jacksonville and St. Augustine,
Florida area. The diverse group is currently made up of cardiology
and vascular specialists including non- invasive, two neurologists,
a sleep neurologist, invasive, electrophysiology and coronary and
peripheral vascular interventionalists, carotid interventionalists
and looking to add a neurologist to our private group. This
position will most likely be based in St. Augustine and Palatka,
Florida. We are seeking a neurologist who can join this very busy
practice. In addition to general neurology, the ideal candidate will
be able to contribute immediately to some or all of the many
hospital and clinic based services including stroke management.
The group has its own fully accredited cath lab, digital
echocardiography labs, non-invasive accredited vascular labs with
RVTs on staff, accredited nuclear medicine, sleep lab, venous clinic
and research departments. The northeast Florida coast area is known
for its historic and natural beauty and provides all of the amenities
of a large city along with the benefits of living in small close knit
communities. In addition to the many cultural attractions this area
has year round mild temperatures, affordable housing and top rated
schools. This is a very rewarding partnership track opportunity for
the right candidate to join a group of well-respected colleagues who
work well as a team. Reasonable call schedule, competitive salary
and benefits. Email dpittman@firstcoastcardio.com
Neurologist – Tacoma, WA Group Health Physicians, the Pacific
Northwest’s premier multi-specialty group, is currently seeking
BC/BE Neurologist to join our Tacoma Medical Center. The ideal
candidate(s) for this outpatient only opportunity will have a
MS/Behavioral Neurology Fellowship and an interest in an
innovative group practice. Competitive salaries and generous
benefit packages are offered. Flexible schedules and outstanding
teams make this opportunity worth exploring. For additional
information or to submit your CV, please contact: Jenelle Van Assen,
vanassen.j@ghc.org. GHP Recruiting. (800) 543-9323
Pediatric Neurologist The Section of Pediatric Neurology at
Children’s Hospital at Dartmouth is adding another Pediatric
Neurologist. We seek a Board certified/eligible motivated
neurologist who has general and clinical pediatric neurology skills
with a strong interest in teaching. Subspecialty skills or research
interests are encouraged and will be supported. There is also
potential opportunity to engage in regional development. The
position includes appointment to the faculty of the Department of
Pediatrics and Dartmouth Medical School at a rank commensurate
with experience and academic portfolio. Currently, our section
consists of several talented, dedicated individuals who enjoy living
and working in a beautiful rural setting with all the benefits of a
top-notch academic medical center and nearby Dartmouth College.
Full-time preferred but part-time interest considered. The Upper
Valley is ranked highly as a desirable place to live and work with
wonderful recreational and cultural opportunities, proximity to
Boston and Montreal and excellent local schools. Interested
candidates should send their CV’s and Letters of inquiry
electronically to: Richard P. Morse, MD, Chief of Child Neurology
and Development, Children's Hospital at Dartmouth, DartmouthHitchcock Medical Center, Olivia.E.Chapman@Hitchcock.org.
Dartmouth-Hitchcock Clinic is an affirmative action/equal
opportunity employer and is especially interested in identifying
female and minority candidates. www.Dartmouth-Hitchcock.org
General Neurologist: Western Wisconsin Nestled near the
Wisconsin/Minnesota border, the beautiful western WI communities
of Hudson and New Richmond boast newly remodeled hospitals,
excellent nursing and clinic support staff, and a strong and
fast-growing patient base. Qualified, experienced BC'd candidates
will have an entrepreneurial spirit and desire to practice communitybased general neurology, while benefiting from the stability, support
and camaraderie of our larger Neurology group in nearby St. Paul,
MN. An exciting, rewarding practice, a highly competitive benefits
and comp package, paid malpractice, and great colleagues await.
Forward your CV and cover letter to lori.m.fake@healthpartners.com
or apply online at www.healthpartners.jobs. EOE. HealthPartners
Medical Group; healthpartners.com
The Clinical Neurophysiology Fellowship Opening The
Department of Neurology at Henry Ford Hospital is offering two
positions for fellows in EEG track and one position in EMG track of
Clinical Neurophysiology Fellowship beginning July 2012. This is a
one-year ACGME accredited fellowship that provides an extensive
training in Clinical Neurophysiology. We offer five positions every
year. On completion of the fellowship, the fellows gather far-reaching
skills in more than one of the following: EEG, video/EEG monitoring,
critical care monitoring (CCM), magnetoencephalography (MEG),
evoked potential (EP) studies, sleep studies, EMG/ neuromuscular
training including Botox injections, muscle/nerve biopsies and
autonomic function test. Fellows are required to participate in
clinical research project. Candidates should send their CV, letter of
interest and 3 letters of recommendations to: Terry Bell (Fellowship
Coordinator), Department of Neurology (K-11), 2799, W. Grand Blvd,
Henry Ford Hospital, Detroit, MI 48202. Phone: (313) 916-7205.
Fax: (313) 916-5117
Neurointensivist needed in Sacramento, CA Mercy Medical
Group is a multi-specialty group with more than 260 healthcare
providers in the Sacramento, CA region and is the premier provider
of Neurology services in the area. We are seeking a BC Neurologist
with fellowship training/certification in Neurological Critical Care.
The candidate will be a member of our diverse Division of Neurology
working within an integrated hospital system with an established
Neurointensivist and hospital-based Neurology Program. Strong
leadership capabilities and willingness to collaborate with physician
leaders, nursing leaders and service-line administrators is required.
This candidate will be responsible to help formalize and grow the
Neurological Critical Care service for Mercy Neurological Institute
of Greater Sacramento to ensure high quality, safe and effective
care for patients affected by catastrophic emergent neurological
injury and neurological complications in critically ill patients in our
Neuro-ICU. This individual will provide service in direct support of
the Mercy Neurological Institute of Greater Sacramento at Mercy
San Juan Medical Center (www.mercysanjuan.org), a level 2
trauma center, with secondary services at Mercy General Hospital
(www.mercygeneral.org), a tertiary level facility for heart and
vascular disease. Both facilities are Joint Commission Certified
Primary Stroke Centers offering a complete interdisciplinary stroke
intervention team including neurosurgeons, neuro-interventional
radiology, and bi-plane angio neurointerventional suite Mercy
Neurological Institute (www.mercyneuro.org) is a market leader
and is actively involved in clinical research trials and consistently
setting the community standard for patients affected by
neurological diseases. This shareholder track opportunity offers a
very competitive compensation and benefits package, including
bonus potential and a very desirable retirement plan. Mercy
Medical Group (www.mymercymedgroup.org) is a service of CHW
Medical Foundation (CHWMF). CHWMF is affiliated with Catholic
Healthcare West, one of the leading healthcare systems in the
country. For more information, please contact Colin Harris,
Sr. Physician Recruiter, at (916) 733-3415 or colin.harris@chw.edu.
BC/BE Adult Neurologist A growing, busy, well established
practice in South Carolina is seeking a hard working general
neurologist. EMG expertise and/or sleep a plus. Other
subspecialties welcomed. Join three other experienced
neurologists. One in four call, practice owned sleep lab, EEG,
EMG and state of the art open bore MRI. Market responsive
salary with bonus possible first year. Early partnership,
comprehensive benefits and retirement plan provided. Near
Charlotte, NC and close proximity to the mountains and beaches.
Email: pmyers@metrolinaneurology.com
Neurologist / Southeast Pennsylvania suburbs Southeast
Pennsylvania suburbs. Excellent opportunity for BE/BC
Neurologist to join busy 3-person private practice in the SE
Pennsylvania suburbs. We have one office and are the primary
Neurology group at a community-teaching hospital where we
also administer the stroke program. We offer excellent benefits,
competitive compensation, potential partnership, and a
stimulating and supportive environment. Interested candidates,
please E-mail CV to: SEPANeuro@gmail.com
BC/BE Neurologist Looking for a fantastic quality of life with an
exciting and challenging new opportunity? Please consider the
following opportunity: Seeking a hardworking, reliable and
personable BC/BE neurologist to join of a very busy and growing
adult neurology and pain management practice in Northern Virginia
for expansion of Neurohospitalist/stroke program. Generous 200K
starting Salary plus production bonus and benefits. Excellent
specialists and ancillary staff for support. Stroke training and/or
experience developing a program a plus. Imagine a community
where history is alive, cultural offerings is abundant and housing
prices are affordable. Northern VA has a dynamic and growing
population, with opportunities for each member of the family;
please consider this diverse Community located in Woodbridge, VA.
With Washington DC only 35 miles away you will be more than
satisfied with calling this community home. This community also
offers strong local economy, public and private schools with magnet
level and college prep courses, major universities and colleges
located nearby, first class restaurants, outdoor activities, cultural
amenities and a vibrant night life of our Nation’s Capital. Enjoy the
Washington DC’s Theatres, Museums, zoo, concerts, professional
baseball, football, hockey, basketball and more. Easy access to the
Atlantic Beaches. Live nearby in the community or commute from
northern Virginia and Washington DC only 35 miles away. We want
to talk to you. We will sponsor H-1. Send CV and letter of interest to
oraees@aol.com.
Neurologist Actively recruiting BC/BE Neurologists to be the 5th
or 6th in busy practice on the central east coast of Florida. Benefit
from the support and stability of an established practice. Need both
a neuro-hospitalist and an office-based neurologist. Full time or part
time. Untapped growth potential offering salary with quarterly
incentive bonus and opportunity for partnership. Benefits include
paid malpractice, health insurance, 401K and CME allowance.
Principle hospital is 514 beds with certified stroke center. Small
town feel offering camping, biking, fishing, boating, ocean beaches
5 minutes away, space program and great schools. Only 30 minute
drive from Orlando, with nearby NBA team, international airport,
Disney, and other entertainment/dining activities. Contact Melinda
at (321) 984-9400 x3109 or Melinda@theneurologyclinic.net.
Neurology Position in South Miami, Florida Neurology
Opportunity in South Miami, Florida. Seeking a general or
sub-specialty trained Neurologist, BC/BE, to join a highly regarded,
well-established 5 Physician practice. The office is affiliated with
South Miami Hospital, a Baptist Healthcare System hospital that is a
Primary Stroke Center enjoying an excellent reputation for quality
care. This office is a hospital based office in a modern building,
enclosed garage and covered connection to the hospital. Competitive
salary and benefit package. This is an excellent opportunity for
personal and professional growth. We offer a collegial environment
with a strong infrastructure. Interested candidates are invited to
send their CV tobsmehle@neuroscienceconsultants.com
Neurologists Well-established, quality oriented neuroscience
group seeks to add additional neurologists to our team, including a
rehabilitative neurologist, pediatric neurologist, and general
neurologist. We are a multidisciplinary neuroscience group providing
a strongly collaborative environment and opportunities for professional
growth. Our location offers easy access to the cultural institutions
of Boston, the mountains, the ocean, as well as outstanding private
and public school opportunities for children. Send C.V. to Howard M.
Gardner, M.D., Medical Director, New England Neurological
Associates, P.C., RIVERWALK, 354 Merrimack Street, Lawrence,
MA 01843, or email to jtf@neneuro.com. Visit us on the web at
www.neneuro.com.
General Neurology Ochsner Health System is seeking a Board
Certified/Board Eligible General Neurologist to practice at Ochsner
Medical Center Kenner. While this is primarily an outpatient position,
there is also responsibility on the hospital consult service. This
physician will become a part of Ochsner Health System’s growing
21-physician Neurology Department. The neurology team includes
neurologists with subspecialty expertise in stroke, neurointensive
care, movement disorders, epilepsy, pain management, neuroimmunology, neuromuscular disorders, and neuroimaging. Bi-lingual
candidates are preferred but not required. Candidates may apply
directly from training or from practice. Ochsner Medical Center
Kenner is a 125-bed acute care community hospital located in
suburban New Orleans. More than 500 employees and 350 physicians
are on staff to provide outstanding care to the patients. Ochsner
Health System is a physician-led, non-profit, academic, multispecialty healthcare delivery system employing over 800 physicians
throughout Southeast Louisiana. We offer a generous and
comprehensive benefits package. We also enjoy the advantage of
practicing in a favorable malpractice environment in Louisiana.
Please visit our website at www.ochsner.org. New Orleans is a
cosmopolitan, historic city with unique architecture, multiple medical
schools and academic centers, professional sports teams, world-class
dining and cultural interests, and world-renowned live entertainment
and music. Please e-mail CV to: ochsnerphysiciancv@gmail.com,
Ref #AGNK03. (800) 488-2240. EOE. Sorry, no J1 visa opportunities
available.
Neurointensivist/Neurovascular Ochsner Health System
North Shore is seeking the following Board Certified/Board Eligible
Neurologists: General Neurologist to join a planned group of four
neurologists, including 3 general neurologists and 1 Interventional
Neurologist/Stroke Specialist. Sub-specialty interest is encouraged.
Vascular Neurologist/Interventional Neurologist to lead the
development of a Primary Stroke Center at Ochsner Medical
Center-North Shore. An interventional suite is currently available at
the hospital. Acute stroke consultations are available in the
emergency room through stroke telemedicine consults, currently in
place in 11 sites in south Louisiana. This physician will join a group
of 4 members in the Stroke and Neuro-Critical Care Division of the
Department of Neurology. These physicians will become a part of
Ochsner Health System’s growing 21-physician Neurology
Department. This neurology team includes neurologists with
subspecialty expertise in stroke, neurointensive care, movement
disorders, epilepsy, pain management, neuroimmunology,
neuromuscular disorders, and neuroimaging. Teaching
involvement with medical students and residents is encouraged
but not required. The telemedicine stroke program at Ochsner
Medical Center-North Shore is integrated with our large tertiary
care center on Jefferson Highway in New Orleans. In addition,
the North Shore will have the availability of neuro-subspecialists
in movement disorders, epilepsy, cognitive disorders, and MS on
a regular and periodic basis. The North Shore Region offers an
excellent referral base with over 100 physicians and mid-level
providers with ten locations in five communities. Ochsner Health
System is a physician-led, non-profit, academic, multi-specialty,
healthcare delivery system employing over 800 physicians
throughout Southeast Louisiana. We conduct over 300 ongoing
clinical research trials annually. We offer a generous and
comprehensive benefits package. We also enjoy the advantage
of practicing in a favorable malpractice environment in Louisiana.
Please visit our website at www.ochsner.org. Please e-mail CV to
ochsnerphysiciancv@gmail.com. Call (800) 488-2240. Ref #. EOE.
Sorry, no J-1 visa opportunities available.
General Neurology & Vascular/Interventional Neurology Ochsner Health System in New Orleans is seeking a Board Certified/
Board Eligible Neurologist with fellowship training in Neurointensive
Care or Neurovascular to join its large tertiary referral program.
Interest in acute stroke care, participation in a stroke fellowship
training program, teaching in a neurology residency program, care of
neurosurgical patients, interacting with a robust stroke program and
an active tertiary referral program for neurological disease are all
important. Interest in neuroscience is preferred but not required.
Both newly trained and experienced physicians are encouraged to
apply. Ochsner Health System’s growing 21-physician Neurology
team includes neurologists with subspecialty expertise in stroke,
neurointensive care, movement disorders, epilepsy, pain management,
neuroimmunology, neuromuscular disorders, and neuroimaging.
Ochsner’s Department of Neurology is a recipient of the HealthGrades
Stroke Care Excellence Award with a five-star ranking. In addition,
we ranked #1 in Louisiana for the treatment of stroke. We also have
an accredited EMG and Sleep lab. Ochsner Health System is a
physician-led, academic, multi-specialty, non-profit healthcare delivery
system. We employ over 800 physicians, and our system includes
8 hospitals and 38 health centers. We also enjoy the advantage of
practicing in a favorable malpractice environment in Louisiana.
Please visit our website, www.ochsner.org for more information.
Ochsner Health System and The University of Queensland Medical
School in Brisbane, Australia began a unique, joint partnership in
2009 by opening the University of Queensland School of Medicine
Clinical School at Ochsner, providing U.S. medical students with
an unprecedented educational experience. New Orleans is a
cosmopolitan, historic city with a pleasant climate, unique
architecture, multiple medical schools and academic centers,
professional sports teams, world-class dining and cultural interests,
and world-renowned live entertainment and music. Please email
CV to ochsnerphysiciancv@gmail.com, or call: (800) 488-2240 for
additional information. Ref #ARNN05. EOE. Sorry, no J1 visa
opportunities available.
Employed Neurology and Epilepsy Opportunities Neurological
Associates, a well-established, employed practice of 16
Neurologists and Neurosurgeons in Columbus, Ohio, is seeking a
Vascular Neurologist. Practice at Riverside Methodist Hospital, a
1,000+ bed, tertiary care teaching hospital. Riverside ranks 1st in
inpatient stroke volume in Ohio and was named a “Top 50 Neurology
and Neurosurgery Hospital” by U.S. News & World Report. Participate
in OhioHealth’s Stroke Network, which involves a partnership
between local and remote hospitals via telemedicine, to provide the
most advanced stroke care. Plans set to build a new Neuro tower,
which will expand neurological services and give Riverside the only
dedicated neuro tower in the region. Neurological Associates
practices cutting-edge stroke treatments and offers teaching
opportunities to its physicians. Enjoy working with a support system
of 9 Neurologists and 5 full-time NPs. Practice in the 15th largest
city in the nation and Ohio’s capital. Contact Ilene Morrow,
Physician Recruiter, at (614) 544-4222 or morrowi@ohiohealth.com
Vascular Neurology Physician A well-established practice of
16 Neurologists and Neurosurgeons in Columbus, Ohio is seeking a
Neurologist and an Epileptologist. The group is comprised of some
of the most highly regarded physicians in the Midwest. Practice at
Riverside Methodist Hospital, a “Top 50 Neurology and Neurosurgery
Hospital” by U.S. News & World Report. Employed practice with
competitive compensation and retirement packages. Riverside has
the 2nd highest Neuroscience volume in the state and ranks 1st in
inpatient stroke volume. Opportunity to work with OhioHealth’s
Stroke Network involving local and remote hospitals via telemedicine
to provide advanced stroke care. The Epileptologist will have the
opportunity to assist in the development of our growing Epilepsy
program. Plans in place to build a new neuro tower, expanding our
neurological services and will be the only dedicated neuro tower in
the region. For more information, please contact Ilene Morrow at
(614) 544-4222, or email your CV to morrowi@ohiohealth.com.
35
UPCOMING DATES AND DEADLINES
Neurointensivist/Hospitalist Sacred Heart Medical Center a
regional referral center has an outstanding clinical opportunity in
western Oregon for an energetic BE/BC hospital based Neurologist
with an interest/experience in Vascular and/or Neurocritical Care.
The ideal candidate will act as a hospital consultant to assist in the
management of patients with stroke and other acute neurologic
conditions. This position is fulltime, hospital employed with
competitive compensation and comprehensive benefits. We seek an
individual who would have an interest in our Joint Commission
certified primary stroke program, clinical research and tele-medicine
services. This individual will excel and enjoy consulting with primary
care physicians. Critical care experience required. Eugene, Oregon
is one of the most desirable cities in the Pacific Northwest in which
to live, work and play. The area is extraordinarily rich in recreational
areas as well as cultural activities and the arts. With only an hour’s
drive you can also find adventures at the beach or the mountains.
Send CV to Nancy Dunlap at: ndunlap@peacehealth.org or fax to
(541) 349-8036, or call Nancy at (541) 222-2502.
Neurointensivist/Hospitalist Sacred Heart Medical Center a
regional referral center has an outstanding clinical opportunity in
western Oregon for an energetic BE/BC hospital based Neurologist
with an interest/experience in Vascular and/or Neurocritical Care.
The ideal candidate will act as a hospital consultant to assist in the
management of patients with stroke and other acute neurologic
conditions. This position is fulltime, hospital employed with
competitive compensation and comprehensive benefits. We seek an
individual who would have an interest in our Joint Commission
certified primary stroke program, clinical research and tele-medicine
services. This individual will excel and enjoy consulting with primary
care physicians. Critical care experience required. Eugene, Oregon is
one of the most desirable cities in the Pacific Northwest in which to
live, work and play. The area is extraordinarily rich in recreational
areas as well as cultural activities and the arts. With only an hours
drive you can also find adventures at the beach or the mountains.
Send CV to Nancy Dunlap at: ndunlap@peacehealth.org or fax to
(541) 349-8036, or call Nancy at (541) 222-2502.
Medical Director - Stroke Program Opportunities for BC/BE
Vascular and General Neurologists to complement an existing
two person Neurology practice, part of Saint Francis Medical
Group, a 200 provider multi-specialty group affiliated with Saint
Francis Hospital and Medical Center in Hartford, CT. Existing
Neurologists include a Stroke and General Neurologist,
complemented by two Nurse Practitioners. To qualify for the
Vascular Neurology position, you will have completed a
fellowship in Vascular Neurology and be BC/BE. Responsibilities
include inpatient general neurology and stroke consultations, as
well as outpatient neurology; call 1:4. Saint Francis Hospital and
Medical Center is a 617-bed tertiary care hospital located in
Hartford, CT and has a Joint Commission and CT DPH accredited
Stroke Center. The hospital is affiliated with the University of
Connecticut for both undergraduate and graduate medical
education. Contact Christine Bourbeau, Director, Physician
Recruitment, at 855.894.5590 or email your Curriculum Vitae to
cbourbea@stfranciscare.org website: www.stfranciscare.org
Vascular and General Neurology Opportunities - Central
Connecticut Are you a BC Vascular Neurologist seeking to advance
your career as a leader within a comprehensive stroke program? We
can make that happen. Saint Francis Hospital and Medical Center
has an exciting opportunity for an exceptional Vascular Neurologist
to serve as the Medical Director of our Stroke Program within our
comprehensive Stroke Center in Hartford, CT. This is an opportunity
to lead an established multi-disciplinary team, develop clinical
expertise, and provide a vision for our Stoke Program’s continued
advancement. This position benefits from an academic affiliation
with the University of Connecticut and multi-specialty support from
one of the largest hospitals in Connecticut. The ideal candidate should
have demonstrated an ability to lead in a clinical team environment,
have an outstanding history of clinical care and an interest in
teaching and providing visionary leadership. If you are ready to
advance in your career, we can make that happen. Contact Christine
Bourbeau today at (855) 894-5590 or email your CV and letter of
interest to cbourbea@stfranciscare.org. www.saintfranciscare.com
Neurologist GWV The Geisinger Neurosciences Institute at
Geisinger Wyoming Valley Medical Center in Wilkes-Barre, PA, is
seeking a stroke neurologist, a general neurologist, a Neurohospitalist,
and an aging brain specialist for its rapidly expanding department.
Located within 2.5 hours of New York City and Philadelphia, this region
offers an excellent quality of life with access to numerous activities
and affordable housing. Geisinger Health System is a physician-led,
patient-focused, integrated delivery system that uses a mature
electronic health record connecting more than 800 physicians
over a 40-county area serving nearly 3 million people. Visit
www.join-geisinger.org or contact Lori Surak at ljsurak@geisinger.edu
or (800) 845-7112.
BC/BE Neurologist & Pediatric Neurologist This Place is
Amazing. So is the difference you can make. Greenville Hospital
System University Medical Center (GHS), the largest healthcare
provider in South Carolina, is seeking a BC/BE Neurologist to join our
dynamic team. BC/BE Neurologist: The Neurology Department has
established a protocol driven multi-disciplinary approach to treating
a variety of neurological diseases, injuries and pain, including but not
limited to epilepsy, movement disorders, neurophysiology and
strokes. This Department combines efforts with Neurosurgery and
Physiatry. We're also seeking a Pediatric Neurologist to work at our
Children's Hospital that offers a broad range of comprehensive
subspecialty services. Our system includes clinically excellent facilities
with 1,268 beds on 5 campuses. Additionally, we offer 7 residency
programs, 5 fellowships, a level-one trauma center and a research
facility. And in 2012, our Medical School will be opening in conjunction
with USC at our main downtown campus. Greenville, South Carolina
is located on the I-85 corridor between Atlanta and Charlotte, and is
one of the fastest growing areas in the country. We are ideally
situated near beautiful mountains, beaches and lakes. We offer a
great compensation package that includes excellent benefits. Qualified
candidates should submit a CV to: Ericka Splawn, Physician Recruiter,
at esplawn@ghs.org. Or call (877) 360-5579. www.ghs.org. No Visa
Sponsorship available. Greenville Hospital System University Medical
Center is an equal opportunity employer which proudly values
diversity. Candidates of all backgrounds are encouraged to apply.
Country Doctor? Big-City Superstar? Be Both. Tanner Health
System, the healthcare provider of choice in west Georgia and east
Alabama, has an immediate opening for two neurologists. Join Tanner
Neurology, an established practice that is part of Tanner Medical
Group, one of metro Atlanta’s largest multi-specialty physician groups.
Practice as an employed physician from a single, outpatient office
location with 1:4 hospital call rotation, serving a dynamic community
on the outskirts of Atlanta with unparalleled charm and character,
excellent schools and recreational opportunities, a thriving arts scene,
a state university and more. Call (770) 838-8729 or email
ejohnston@tanner.org for more information on this excellent
opportunity. Learn more at www.tannerphysicianrecruitment.org.
Seeking Neurologist For Spine Center Diagnosis/Initial
Consult The New Jersey Center For Spinal Disorders seeks an
energetic and skilled neurologist to assist in the diagnosis,
evaluation, and management of patients with spinal disorders.
We have a bright, newly renovated office in the heart of beautiful
Englewood, NJ located only 5 miles from New York City. Just
down the street from Englewood Hospital, and Health East
Medical Center. To learn more about this opportunity, please
contact us directly, or submit your CV. www.mybackcure.com
Employed Neurology Arizona Scottsdale Healthcare (SHC) Shea
is seeking a Fellowship Trained Epileptologist with experience to
establish and run a new Epilepsy Monitoring Unit which will
encompass outpatient epilepsy clinic services and in-patient
services involved with the operation of the EMU. As an Employee of
Scottsdale Healthcare, you will have exceptional team support and
necessary technical, administrative and marketing resources for the
development and on-going success of a World Class Epilepsy
Program. The Epilepsy Program will be a destination center for the
region as accessibility to EMU services is vastly underserved in the
state of Arizona. In addition, you will have the opportunity to
maintain your general Neurology skills providing Neuro-Hospitalist
services for approximately eight weeks per year. All in-patient and
out-patient clinical services will be provided at the SHC Shea
Campus, located in desirable North Scottsdale with excellent
schools, restaurants and year round recreation as a city built in the
base of beautiful McDowell Mountains. In addition, Scottsdale
Health care offers exceptional benefits to include professional
liability, relocation, housing allowance and many other benefits you
would expect from a system devoted to "World Class Patient Care."
Please call Laura Hays (480) 391-9777 or (888) 391-9777 or email
CV LHays@TrekPhysician.com or fax (480) 772-4566
Epileptologist/Neuro-Hospitalist The Practice: Practice in a
community where you can make a difference. Medical staff will
welcome your expertise in Neurological services. Patients will benefit
from not having to travel. Practicing and 2012 Neurology Residents
encouraged to apply. TeleStroke consultation and access to Medicine
Ground Rounds provided via contract with Mayo Clinic Scottsdale.
Hospital Employed position offers: competitive salary guarantee,
comprehensive Benefits, malpractice insurance, relocation expenses.
Hospital is financially sound. Medical staff is collegial and opted to
practice in the white mountains to avoid the hassles and politics of
metro area medicine. Life is good when you remove stress points
(traffic, politics, competition etc.). The Region: the white mountains
is comprised of several close knit communities of full-time residents
surrounded by resort communities that attract visitors that enjoy
hiking, fishing, hunting, golf, water sports, snow skiing and nice
people. Please call Laura Hays 480-391-9777 or (888) 391-9777 or
email CV LHays@TrekPhysician.com or fax (480) 772-4566.
General Neurologist Needed for Busy East Texas Practice Your
opinion will be valued as a member of our dynamic neuroscience
team. Trinity Mother Frances Hospitals and Clinics in Tyler, Texas,
home to one of the most comprehensive neurosurgery programs in
east Texas, is adding a fifth neurologist to our growing department.
Trinity Mother Frances Neuroscience Institute is staffed by specialists
in neurosurgery, neurology, physical medicine and rehabilitation, pain
medicine, sleep medicine and stroke. Combined with the awardwinning clinical resources of Mother Frances Hospital, we offer
state-of-the-art patient care facilities and the latest surgical and
treatment technologies. Enjoy an outstanding production-based
compensation package; relocation assistance, no tail malpractice and
no clinic buy in. Tyler is a major medical referral center with more than
one million draw and is a growing certified retirement community. If
you’re seeking an exceptional lifestyle balance, this is the opportunity
for you. Trinity Clinic is comprised of over 270 physicians in
37 specialties serving north central, east, and northeast Texas.
Community Description: Tyler is located just 100 miles from Dallas
and is recognized as among the most desirable places to work and is
also a certified retirement community. A national leader in patient
satisfaction, advanced technology and quality initiatives, Trinity
Mother Frances is a faith-based, not-for-profit organization dedicated
to creating healthy lives for people and communities. For additional
information, please contact Tonya Hamlin, Director, Physician
Recruitment, hamlint@tmfhs.org. (903) 531-4906. Code: MFH032211
Seeking Neurologists General and interest in Epileptology UPMC Hamot in Erie, Pennsylvania is seeking a general neurologist
with training and interest in hospital based care and/or epileptology
to join a busy physician owned neurology practice. This is an
excellent opportunity to join a rapidly growing Neuroscience Service
Line at a Level 2 Trauma Acute care Medical Center that includes a
neurology residency program. Call will be 1:8 as well as excellent
compensation and benefits. Lifestyle that includes living along Lake
Erie. Contact Sue McCreary, Physician Recruiter at (814) 877-3403
or sue.mccreary@hamot.org. Visit us at www.hamot.org.
Neurologist Wenatchee Valley Medical Center in North Central
Washington State is seeking a 5th Neurologist. Practice is 90%
outpatient; inpatient is consultative with robust hospitalist
program. General neuro with sub-specialty interest welcome,
clinical neuro-physiology fellowship preferred. We’re the only
Neurologists for 12,000 sq. miles; patient draw of 235k.
Market-responsive salary, partnership, comprehensive benefits,
retirement. Paperless and efficient. Collegial medicine at its best.
Physician-owned and patient-centered since 1940. Now that’s
Serious Medicine. Over 300 days of sunshine with mild 4-season
climate amidst mountains, rivers, and lakes. Skiing, biking, paddling,
golf, you name it. No traffic jams. “Small” town of 65k with plenty
of amenities. Yeah, Serious Fun. Email CV to Peter Rutherford, MD
at JoinUs@wvmedical.com. Learn more at www.wvmedical.com.
SEPTEMBER 2011
SUN
MON
TUE
WED
OCTOBER 2011
THU
FRI
SAT
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
18
19
20
21
22
23
25
26
27
28
29
30
SEPTEMBER 18
Application Deadline: Palatucci
Advocacy Leadership Forum
www.aan.com/view/2012PALF
Melissa Larson
mlarson@aan.com
SEPTEMBER 20
Win, Lose, or Draw? Negotiating
with Hospitals and Insurers
(Register by September 16)
www.aan.com/go/practice/coding/
conferences
Christi Kokaisel
ckokaisel@aan.com
SUN
MON
TUE
WED
THU
NOVEMBER 2011
FRI
TUE
WED
THU
FRI
1
2
3
4
5
4
5
6
7
8
6
7
8
9
10
11
12
17
9
10
11
12
13
14
15
13
14
15
16
17
18
19
24
16
17
18
19
20
21
22
20
21
22
23
24
25
26
23
24
25
26
27
28
29
27
28
29
30
30
31
OCTOBER 10–14
Neurology Career Week
Create your online career profile
www.aan.com/career
OCTOBER 15
Application Deadline: 2012-2013
Viste Neurology Public Policy Fellowship
www.aan.com/viste
Mike Amery
mamery@aan.com
OCTOBER 18
OCTOBER 21–23
2011 Fall Conference, Las Vegas, NV
www.aan.com/view/fall2011
OCTOBER 24
Deadline: Abstract Submissions
for 2012 Annual Meeting
Erin Jackson
ejackson@aan.com
(651) 695-2704
NOVEMBER 1
Deadline: AAN Scientific Awards
www.aan.com/2012awards
Erin Jackson
ejackson@aan.com
(651) 695-2704
Deadline: Patient Safety Award
Amy Wallace
awallace@aan.com
(651) 695-2817
Deadline: Resident Scholarship
to the Annual Meeting
Cheryl Alementi
calementi@aan.com
(651) 695-2737
Deadline: Program Directors
Recognition Award
Lucy Persaud
lpersaud@aan.com
(651) 695-2741
Deadline: International
Scholarship Award
Franziska Schwarz
fschwarz@aan.com
(651) 695-2807
NOVEMBER 8
ICD-10: What You Need to
Know for 2012
(Register by November 4)
conferences
Christi Kokaisel
ckokaisel@aan.com
(651) 695-2810
NOVEMBER 30
AANnews Classified Advertising
Deadline: Kenneth M. Viste, Jr., MD,
Patient Advocate of the Year Award
Julie Grengs
jgrengs@aan.com
(651) 695-2755
The AAN offers a complete package of print,
online, and in-person recruitment advertising
opportunities. Visit www.aan.com/careers
for all AAN options, rates, and deadlines.
Ad copy for the November 2011 print
edition of AANnews must be submitted by
October 1, 2011. The same deadline applies
to changes/cancellations.
The American Academy of Neurology reserves the
right to decline, withdraw, or edit advertisements
at its discretion. Every care is taken to avoid
mistakes, but the responsibility for clerical or
printer errors does not exceed the cost of the ad.
SAT
3
SEPTEMBER 30
Baltimore, Maryland Area Baltimore, Maryland area: Seeking
BC/BE neurologist to join a busy highly-respected suburban general
neurology private practice, affiliated with several local community
and teaching hospitals. EEG/EMG fellowship training and/or
experience preferred but not mandatory. Flexible compensation
and benefits package with early partnership available for qualified
candidate. Locale enjoys reasonable cost of living enhanced by
many cultural, recreational, and educational opportunities too
numerous to list. Visit website at www.taylormedicalgroup.com.
Mail detailed contact information and resume to: Richard L. Taylor,
MD, FAAN, Taylor Medical Group, 22 West Road, Suite 101,
Towson, MD 21204-2388.
MON
2
Deadline: AAN Fall Conference
Early Registration Discount
www.aan.com/view/fall2011
Registration Deadline: EBM Toolkit
Training
www.aan.com/education/ebm
Rebecca Penfold Murray
rpenfoldmurray@aan.com
(651) 695-2735
SUN
1
Coding Accurately for Epilepsy
(Register by October 14)
conferences
Christi Kokaisel
ckokaisel@aan.com
(651) 695-2810
SEPTEMBER 27
SAT
AAN FALL CONFERENCE
AAN ANNUAL MEETINGS
2011 / Las Vegas
October 21–23
2012 / New Orleans
April 21–28
2013 / San Diego
March 16–23
2014 / Philadelphia
April 26–May 3

September edition - American Academy of Neurology

Transcription

Similar documents

2015 Annual Meeting Medical Students, Residents, and Fellows Guide

Early Registration Deadline: June 9, 2014

Wenner van die Hangklip-Kleinmond Toerisme Braaidag Kompetisie

treatment of painful diabetic neuropathy

Scientific Abstract Listing and Meeting Information

June 9 - 12, 2015 Toronto, Ontario

Training Workshop: Kamiskroon

W-12 view

Scientific Abstract Listing and Annual Meeting Information

Sinapse - Sociedade Portuguesa de Neurologia

PDF of the event booklet - The Worshipful Company of Pewterers